| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | ATP7B HCN2 RYR1 ITPR2 SCN3A KCNJ16 KCNN1 HRH1 NIPA2 ATP13A4 HCN4 ATP13A1 HCN1 CACNA2D4 ATP12A ATP2A1 SLC4A5 CACNA2D3 | 3.80e-06 | 465 | 218 | 18 | GO:0046873 |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 2.74e-05 | 33 | 218 | 5 | GO:0005217 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA4 ATP7B SRPRA RECQL5 DNAH6 ATP13A4 ATP13A1 MYO18A ABCF2 CHD7 DDX55 CCT6B DDX53 ATP12A ATP2A1 SMC1B | 2.94e-05 | 441 | 218 | 16 | GO:0016887 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | ABL2 MYLK3 PIK3C3 NRK AK1 KDR XYLB PPIP5K2 CLP1 KALRN POLE BAZ1B TUT1 REV3L TEC CDC42BPB SEPHS2 STK33 UHMK1 POLI NT5C2 PPIP5K1 ATM PEAK1 MAP3K2 | 3.58e-05 | 938 | 218 | 25 | GO:0016772 |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 4.24e-05 | 36 | 218 | 5 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 4.24e-05 | 36 | 218 | 5 | GO:0015662 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | ATP7B NOX5 HCN2 RYR1 ITPR2 SCN3A KCNJ16 KCNN1 HRH1 NIPA2 ATP13A4 HCN4 ATP13A1 HCN1 CALHM2 CACNA2D4 ATP12A ATP2A1 SLC4A5 CACNA2D3 | 4.30e-05 | 664 | 218 | 20 | GO:0008324 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | ATP7B NOX5 HCN2 RYR1 ITPR2 SCN3A KCNJ16 KCNN1 HRH1 NIPA2 ATP13A4 HCN4 ATP13A1 HCN1 CACNA2D4 ATP12A ATP2A1 SLC4A5 CACNA2D3 | 6.20e-05 | 627 | 218 | 19 | GO:0022890 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | EPRS1 RPS3 PNLDC1 SLFN14 ZRANB3 RPP25 RECQL5 DNMT3B POLE MYO18A TUT1 CHD7 REV3L DDX55 METTL6 MRM3 POLI HLTF DDX53 | 9.00e-05 | 645 | 218 | 19 | GO:0140640 |
| GeneOntologyMolecularFunction | kinase activity | ABL2 MYLK3 PIK3C3 NRK AK1 KDR XYLB PPIP5K2 CLP1 KALRN BAZ1B TEC CDC42BPB SEPHS2 STK33 UHMK1 NT5C2 PPIP5K1 ATM PEAK1 MAP3K2 | 1.02e-04 | 764 | 218 | 21 | GO:0016301 |
| GeneOntologyMolecularFunction | poly(C) RNA binding | 1.19e-04 | 2 | 218 | 2 | GO:0017130 | |
| GeneOntologyMolecularFunction | 5-diphosphoinositol pentakisphosphate 1-kinase activity | 1.19e-04 | 2 | 218 | 2 | GO:0033857 | |
| GeneOntologyMolecularFunction | intracellularly cAMP-activated cation channel activity | 1.46e-04 | 10 | 218 | 3 | GO:0005222 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA4 ATP7B SRPRA ZRANB3 RECQL5 DNAH6 ATP13A4 ATP13A1 MYO18A ABCF2 CHD7 DDX55 HLTF CCT6B DDX53 ATP12A ATP2A1 SMC1B | 1.47e-04 | 614 | 218 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.71e-04 | 26 | 218 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | iron-sulfur cluster binding | 2.11e-04 | 78 | 218 | 6 | GO:0051536 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 2.71e-04 | 152 | 218 | 8 | GO:0022843 | |
| GeneOntologyMolecularFunction | metal cluster binding | 2.96e-04 | 83 | 218 | 6 | GO:0051540 | |
| GeneOntologyMolecularFunction | cyclic nucleotide-activated monoatomic ion channel activity | 3.39e-04 | 13 | 218 | 3 | GO:0043855 | |
| GeneOntologyMolecularFunction | intracellularly cyclic nucleotide-activated monoatomic cation channel activity | 3.39e-04 | 13 | 218 | 3 | GO:0005221 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | RERG ABCA4 ATP7B SRPRA GBP4 RECQL5 DNAH6 ATP13A4 ATP13A1 MYO18A ABCF2 CHD7 DDX55 RHOC RHOH CCT6B DDX53 ATP12A ATP2A1 SMC1B | 3.40e-04 | 775 | 218 | 20 | GO:0017111 |
| GeneOntologyMolecularFunction | aconitate hydratase activity | 3.53e-04 | 3 | 218 | 2 | GO:0003994 | |
| GeneOntologyMolecularFunction | 3 iron, 4 sulfur cluster binding | 3.53e-04 | 3 | 218 | 2 | GO:0051538 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | RERG ABCA4 ATP7B SRPRA GBP4 RECQL5 DNAH6 ATP13A4 ATP13A1 MYO18A ABCF2 CHD7 DDX55 RHOC RHOH HLTF CCT6B DDX53 ATP12A ATP2A1 SMC1B | 3.68e-04 | 840 | 218 | 21 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | RERG ABCA4 ATP7B SRPRA GBP4 RECQL5 DNAH6 ATP13A4 ATP13A1 MYO18A ABCF2 CHD7 DDX55 RHOC RHOH HLTF CCT6B DDX53 ATP12A ATP2A1 SMC1B | 3.68e-04 | 840 | 218 | 21 | GO:0016818 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | NOX5 HCN2 RYR1 ITPR2 SCN3A KCNJ16 KCNN1 HCN4 HCN1 CALHM2 CACNA2D4 CACNA2D3 | 4.09e-04 | 343 | 218 | 12 | GO:0005261 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ATP7B NOX5 HCN2 RYR1 ITPR2 SCN3A KCNJ16 KCNN1 HRH1 NIPA2 ATP13A4 HCN4 ATP13A1 HCN1 CALHM2 CACNA2D4 ATP12A ATP2A1 SLC4A5 CACNA2D3 | 4.55e-04 | 793 | 218 | 20 | GO:0015075 |
| GeneOntologyMolecularFunction | aldehyde dehydrogenase (NAD+) activity | 5.30e-04 | 15 | 218 | 3 | GO:0004029 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 5.78e-04 | 62 | 218 | 5 | GO:0019829 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 6.35e-04 | 262 | 218 | 10 | GO:0140097 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ATP7B NOX5 HCN2 RYR1 ITPR2 SCN3A KCNJ16 KCNN1 HRH1 NIPA2 ATP13A4 HCN4 ATP13A1 HCN1 CACNA2D4 ATP12A ATP2A1 SLC4A5 CACNA2D3 | 6.80e-04 | 758 | 218 | 19 | GO:0015318 |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 3-kinase activity | 7.02e-04 | 4 | 218 | 2 | GO:0052724 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 1-kinase activity | 7.02e-04 | 4 | 218 | 2 | GO:0052723 | |
| GeneOntologyMolecularFunction | aldehyde dehydrogenase [NAD(P)+] activity | 7.79e-04 | 17 | 218 | 3 | GO:0004030 | |
| GeneOntologyMolecularFunction | actin binding | NCALD ABL2 CFL1 ACTN1 ACE HNRNPU S100A4 SVIL VCL PPP1R9A MYO18A FHDC1 CTNNA2 MYBPC3 | 8.28e-04 | 479 | 218 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 8.85e-04 | 140 | 218 | 7 | GO:0099094 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 8.95e-04 | 182 | 218 | 8 | GO:0005244 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | RERG ABCA4 ATP7B SRPRA GBP4 RECQL5 DNAH6 ATP13A4 ATP13A1 MYO18A ABCF2 CHD7 DDX55 RHOC RHOH CCT6B DDX53 ATP12A ATP2A1 SMC1B | 9.15e-04 | 839 | 218 | 20 | GO:0016462 |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 9.60e-04 | 184 | 218 | 8 | GO:0022832 | |
| GeneOntologyMolecularFunction | histone H2AX kinase activity | 1.16e-03 | 5 | 218 | 2 | GO:0141003 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 5-kinase activity | 1.16e-03 | 5 | 218 | 2 | GO:0000832 | |
| GeneOntologyMolecularFunction | diphosphoinositol pentakisphosphate kinase activity | 1.16e-03 | 5 | 218 | 2 | GO:0000829 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate kinase activity | 1.16e-03 | 5 | 218 | 2 | GO:0000828 | |
| GeneOntologyMolecularFunction | inositol-1,3,4,5,6-pentakisphosphate kinase activity | 1.16e-03 | 5 | 218 | 2 | GO:0000827 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.26e-03 | 109 | 218 | 6 | GO:0042626 | |
| GeneOntologyMolecularFunction | transition metal ion binding | EPRS1 ABL2 ATP7B MYCBP2 ACO2 PARK7 MMP20 ACE ZRANB3 PTGR3 TXNRD1 S100A4 MGAT1 HERC2 NOS1 POLE BAZ1B BIRC2 XDH TUT1 DPP3 ZCCHC3 USP5 HLTF RORA | 1.29e-03 | 1189 | 218 | 25 | GO:0046914 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.37e-03 | 151 | 218 | 7 | GO:0015085 | |
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine kinase activity | 1.57e-03 | 46 | 218 | 4 | GO:0004715 | |
| GeneOntologyMolecularFunction | 4 iron, 4 sulfur cluster binding | 1.71e-03 | 47 | 218 | 4 | GO:0051539 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 1.85e-03 | 48 | 218 | 4 | GO:0016620 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | ABL2 MYLK3 PIK3C3 NRK KDR XYLB CLP1 KALRN BAZ1B TEC CDC42BPB STK33 UHMK1 NT5C2 ATM PEAK1 MAP3K2 | 2.08e-03 | 709 | 218 | 17 | GO:0016773 |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase inhibitor activity involved in apoptotic process | 2.19e-03 | 24 | 218 | 3 | GO:0043027 | |
| GeneOntologyMolecularFunction | cAMP binding | 2.47e-03 | 25 | 218 | 3 | GO:0030552 | |
| GeneOntologyMolecularFunction | DNA-directed DNA polymerase activity | 2.47e-03 | 25 | 218 | 3 | GO:0003887 | |
| GeneOntologyMolecularFunction | sodium channel activity | 2.48e-03 | 52 | 218 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCA4 ATP7B NOX5 MCL1 HCN2 RYR1 ITPR2 SCN3A KCNJ16 KCNN1 HRH1 NIPA2 ATP13A4 HCN4 ATP13A1 HCN1 CALHM2 CACNA2D4 SLC25A2 SEC61G ATP12A ATP2A1 SLC4A5 CACNA2D3 | 2.49e-03 | 1180 | 218 | 24 | GO:0022857 |
| GeneOntologyMolecularFunction | mercury ion binding | 3.18e-03 | 8 | 218 | 2 | GO:0045340 | |
| GeneOntologyMolecularFunction | hydroxymethyl-, formyl- and related transferase activity | 3.18e-03 | 8 | 218 | 2 | GO:0016742 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 3.26e-03 | 56 | 218 | 4 | GO:0016903 | |
| GeneOntologyMolecularFunction | actin filament binding | 3.57e-03 | 227 | 218 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | flavin adenine dinucleotide binding | 3.70e-03 | 94 | 218 | 5 | GO:0050660 | |
| GeneOntologyMolecularFunction | transporter activity | ABCA4 ATP7B NOX5 MCL1 HCN2 RYR1 ITPR2 SCN3A KCNJ16 KCNN1 HRH1 NIPA2 ATP13A4 HCN4 ATP13A1 HCN1 CALHM2 CACNA2D4 SLC25A2 SEC61G MTTP ATP12A ATP2A1 SLC4A5 CACNA2D3 | 3.78e-03 | 1289 | 218 | 25 | GO:0005215 |
| GeneOntologyMolecularFunction | poly(A) binding | 3.80e-03 | 29 | 218 | 3 | GO:0008143 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | ATP7B NOX5 PARK7 GAS6 HCN2 RYR1 ITPR2 SCN3A KCNJ16 KCNN1 HRH1 NIPA2 NOS1 ATP13A4 HCN4 ATP13A1 HCN1 CHD7 CALHM2 CACNA2D4 P2RY6 ATP12A ATP2A1 SLC4A5 CACNA2D3 | 1.93e-05 | 942 | 216 | 25 | GO:0098655 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | ATP7B NOX5 PARK7 GAS6 HCN2 RYR1 ITPR2 SCN3A KCNJ16 KCNN1 HRH1 NIPA2 NOS1 ATP13A4 HCN4 ATP13A1 HCN1 CHD7 CACNA2D4 P2RY6 ATP12A ATP2A1 SLC4A5 CACNA2D3 | 3.90e-05 | 922 | 216 | 24 | GO:0098662 |
| GeneOntologyBiologicalProcess | benzene-containing compound metabolic process | 3.99e-05 | 37 | 216 | 5 | GO:0042537 | |
| GeneOntologyBiologicalProcess | biphenyl catabolic process | 6.10e-05 | 8 | 216 | 3 | GO:0070980 | |
| GeneOntologyBiologicalProcess | nucleobase metabolic process | 1.04e-04 | 45 | 216 | 5 | GO:0009112 | |
| GeneOntologyBiologicalProcess | IMP metabolic process | 1.05e-04 | 24 | 216 | 4 | GO:0046040 | |
| GeneOntologyBiologicalProcess | response to organophosphorus | 1.28e-04 | 142 | 216 | 8 | GO:0046683 | |
| GeneOntologyBiologicalProcess | biphenyl metabolic process | 1.29e-04 | 10 | 216 | 3 | GO:0018879 | |
| GeneOntologyBiologicalProcess | metal ion transport | ATP7B GAS6 HCN2 ACE RYR1 ITPR2 SCN3A KCNJ16 KCNN1 HRH1 NIPA2 NOS1 ATP13A4 HCN4 ATP13A1 HCN1 CHD7 CALHM2 CACNA2D4 P2RY6 ATP12A ATP2A1 SLC4A5 CACNA2D3 | 1.37e-04 | 1000 | 216 | 24 | GO:0030001 |
| GeneOntologyBiologicalProcess | purine ribonucleoside monophosphate metabolic process | 1.43e-04 | 48 | 216 | 5 | GO:0009167 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 1.46e-04 | 26 | 216 | 4 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 1.46e-04 | 26 | 216 | 4 | GO:0006063 | |
| GeneOntologyBiologicalProcess | organophosphate metabolic process | PDE9A PARK7 RRM1 SUCLG2 TXNRD1 TTC7B PIK3C3 ALDH1L2 AK1 MCEE XYLB PPIP5K2 TALDO1 NOS1 AMPD1 TIGAR CAPN2 SHMT1 XDH IDH3G P2RY6 NT5C2 PPIP5K1 RORA ATIC ATM | 1.65e-04 | 1142 | 216 | 26 | GO:0019637 |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule metabolic process | PDE9A PARK7 RRM1 SUCLG2 TXNRD1 MGAT1 ALDH1L2 AK1 MCEE TALDO1 NOS1 AMPD1 TIGAR SHMT1 XDH DPYSL4 IDH3G NT5C2 RORA ATIC | 1.73e-04 | 767 | 216 | 20 | GO:0055086 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | ATP7B NOX5 PARK7 GAS6 HCN2 RYR1 ITPR2 SCN3A KCNJ16 KCNN1 HRH1 NIPA2 NOS1 ATP13A4 HCN4 ATP13A1 HCN1 CHD7 CACNA2D4 P2RY6 ATP12A ATP2A1 SLC4A5 CACNA2D3 | 1.76e-04 | 1017 | 216 | 24 | GO:0098660 |
| GeneOntologyBiologicalProcess | purine nucleoside monophosphate metabolic process | 1.91e-04 | 51 | 216 | 5 | GO:0009126 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | ATP7B NOX5 PARK7 GAS6 HCN2 ACE RYR1 ITPR2 SCN3A KCNJ16 KCNN1 HRH1 NIPA2 NOS1 ATP13A4 HCN4 ATP13A1 HCN1 CHD7 CALHM2 CACNA2D4 P2RY6 ATP12A ATP2A1 SLC4A5 CACNA2D3 | 2.03e-04 | 1157 | 216 | 26 | GO:0006812 |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | WBP2 PARK7 HCN2 ACE RYR1 HNRNPU ITPR2 RECQL5 HRH1 HCN4 HCN1 SHMT1 ZCCHC3 SNW1 P2RY6 RORA FLOT1 | 2.27e-04 | 605 | 216 | 17 | GO:0071407 |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 2.32e-04 | 12 | 216 | 3 | GO:0052697 | |
| GeneOntologyBiologicalProcess | AMP metabolic process | 2.59e-04 | 30 | 216 | 4 | GO:0046033 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 2.70e-04 | 85 | 216 | 6 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 2.70e-04 | 85 | 216 | 6 | GO:0000768 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ATP7B NOX5 PARK7 GAS6 HCN2 RYR1 ITPR2 SCN3A KCNJ16 KCNN1 HRH1 NIPA2 NOS1 ATP13A4 HCN4 ATP13A1 HCN1 CHD7 CALHM2 CACNA2D4 P2RY6 ATP12A ATP2A1 SLC4A5 CACNA2D3 | 2.80e-04 | 1115 | 216 | 25 | GO:0034220 |
| GeneOntologyBiologicalProcess | response to hypoxia | MB ACE RYR1 ITPR2 KDR ALDH3A1 DPP4 TIGAR CAPN2 BIRC2 RORA ATM | 3.22e-04 | 348 | 216 | 12 | GO:0001666 |
| GeneOntologyBiologicalProcess | dsRNA transport | 3.25e-04 | 3 | 216 | 2 | GO:0033227 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to cell leading edge | 3.25e-04 | 3 | 216 | 2 | GO:1905871 | |
| GeneOntologyBiologicalProcess | nucleoside monophosphate metabolic process | 3.26e-04 | 88 | 216 | 6 | GO:0009123 | |
| GeneOntologyBiologicalProcess | nucleotide metabolic process | PDE9A PARK7 RRM1 SUCLG2 TXNRD1 ALDH1L2 AK1 MCEE TALDO1 NOS1 AMPD1 TIGAR SHMT1 XDH IDH3G NT5C2 RORA ATIC | 3.29e-04 | 684 | 216 | 18 | GO:0009117 |
| GeneOntologyBiologicalProcess | syncytium formation | 3.47e-04 | 89 | 216 | 6 | GO:0006949 | |
| GeneOntologyBiologicalProcess | myoblast fusion | 3.51e-04 | 58 | 216 | 5 | GO:0007520 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate metabolic process | PDE9A PARK7 RRM1 SUCLG2 TXNRD1 ALDH1L2 AK1 MCEE TALDO1 NOS1 AMPD1 TIGAR SHMT1 XDH IDH3G NT5C2 RORA ATIC | 3.72e-04 | 691 | 216 | 18 | GO:0006753 |
| GeneOntologyBiologicalProcess | response to purine-containing compound | 3.72e-04 | 166 | 216 | 8 | GO:0014074 | |
| GeneOntologyBiologicalProcess | GMP metabolic process | 3.77e-04 | 33 | 216 | 4 | GO:0046037 | |
| GeneOntologyCellularComponent | HCN channel complex | 4.50e-06 | 4 | 219 | 3 | GO:0098855 | |
| GeneOntologyCellularComponent | actin cytoskeleton | ABL2 CFL1 ACTN1 DOCK5 MYLK3 SVIL LPXN VCL KALRN PPP1R9A CAPN2 MYO18A CDC42BPB INTS6 FHDC1 CTNNA2 PEAK1 ATP12A FLOT1 | 1.12e-05 | 576 | 219 | 19 | GO:0015629 |
| GeneOntologyCellularComponent | cation channel complex | HCN2 RYR1 SCN3A KCNJ16 KCNN1 HCN4 HCN1 CACNA2D4 ATP2A1 CACNA2D3 | 1.95e-04 | 235 | 219 | 10 | GO:0034703 |
| GeneOntologyCellularComponent | sarcoplasm | 2.01e-04 | 114 | 219 | 7 | GO:0016528 | |
| GeneOntologyCellularComponent | cell leading edge | RIPOR2 ABL2 PDE9A RPS3 CFL1 ACTN1 HCN2 DAGLA DPP4 HCN1 PPP1R9A CDC42BPB PABPC1 CTNNA2 FLOT1 | 2.70e-04 | 500 | 219 | 15 | GO:0031252 |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 5.96e-04 | 223 | 219 | 9 | GO:0098862 | |
| Domain | Ion_trans_N | 6.31e-06 | 4 | 219 | 3 | IPR013621 | |
| Domain | Ion_trans_N | 6.31e-06 | 4 | 219 | 3 | PF08412 | |
| Domain | - | 3.29e-05 | 32 | 219 | 5 | 3.40.1110.10 | |
| Domain | - | 3.29e-05 | 32 | 219 | 5 | 2.70.150.10 | |
| Domain | HAD-like_dom | 3.92e-05 | 79 | 219 | 7 | IPR023214 | |
| Domain | ATPase_P-typ_cyto_domN | 5.16e-05 | 35 | 219 | 5 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 5.94e-05 | 36 | 219 | 5 | IPR018303 | |
| Domain | P_typ_ATPase | 5.94e-05 | 36 | 219 | 5 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 5.94e-05 | 36 | 219 | 5 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 6.80e-05 | 37 | 219 | 5 | IPR008250 | |
| Domain | E1-E2_ATPase | 6.80e-05 | 37 | 219 | 5 | PF00122 | |
| Domain | - | RERG ABCA4 SRPRA SLFN14 ZRANB3 HNRNPU TRANK1 GBP4 RECQL5 AK1 CLP1 DNAH6 GNL3L MYO18A ABCF2 CHD7 DDX55 RHOC RHOH HLTF DDX53 SMC1B | 6.96e-05 | 746 | 219 | 22 | 3.40.50.300 |
| Domain | BIR | 8.53e-05 | 8 | 219 | 3 | PF00653 | |
| Domain | BIR_REPEAT_2 | 8.53e-05 | 8 | 219 | 3 | PS50143 | |
| Domain | - | 8.53e-05 | 8 | 219 | 3 | 1.10.1170.10 | |
| Domain | BIR_rpt | 8.53e-05 | 8 | 219 | 3 | IPR001370 | |
| Domain | BIR | 8.53e-05 | 8 | 219 | 3 | SM00238 | |
| Domain | BIR_REPEAT_1 | 8.53e-05 | 8 | 219 | 3 | PS01282 | |
| Domain | P-loop_NTPase | RERG ABCA4 SRPRA SLFN14 ZRANB3 HNRNPU TRANK1 GBP4 HS6ST1 RECQL5 AK1 CLP1 DNAH6 GNL3L MYO18A ABCF2 CHD7 DDX55 RHOC RHOH HLTF DDX53 SMC1B | 1.65e-04 | 848 | 219 | 23 | IPR027417 |
| Domain | AconitaseA/IPMdHydase_ssu_swvl | 4.07e-04 | 3 | 219 | 2 | IPR000573 | |
| Domain | Aconitase_C | 4.07e-04 | 3 | 219 | 2 | PF00694 | |
| Domain | Acoase/IPM_deHydtase_lsu_aba | 4.07e-04 | 3 | 219 | 2 | IPR001030 | |
| Domain | - | 4.07e-04 | 3 | 219 | 2 | 3.20.19.10 | |
| Domain | Acoase/IPM_deHydtase | 4.07e-04 | 3 | 219 | 2 | IPR015937 | |
| Domain | Acnase/IPM_dHydase_lsu_aba_1/3 | 4.07e-04 | 3 | 219 | 2 | IPR015931 | |
| Domain | Aconitase/IPMdHydase_lsu_aba_2 | 4.07e-04 | 3 | 219 | 2 | IPR015932 | |
| Domain | Aconitase/3IPM_dehydase_swvl | 4.07e-04 | 3 | 219 | 2 | IPR015928 | |
| Domain | Aconitase | 4.07e-04 | 3 | 219 | 2 | PF00330 | |
| Domain | Aconitase_4Fe-4S_BS | 4.07e-04 | 3 | 219 | 2 | IPR018136 | |
| Domain | - | 4.07e-04 | 3 | 219 | 2 | 3.30.499.10 | |
| Domain | - | 4.07e-04 | 3 | 219 | 2 | 3.40.1060.10 | |
| Domain | ACONITASE_1 | 4.07e-04 | 3 | 219 | 2 | PS00450 | |
| Domain | ACONITASE_2 | 4.07e-04 | 3 | 219 | 2 | PS01244 | |
| Domain | VWA | 4.97e-04 | 56 | 219 | 5 | PF00092 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 5.26e-04 | 14 | 219 | 3 | IPR003938 | |
| Domain | cNMP-bd_CS | 7.96e-04 | 16 | 219 | 3 | IPR018488 | |
| Domain | Ald_DH_CS_GLU | 7.96e-04 | 16 | 219 | 3 | IPR029510 | |
| Domain | DNA_pol_B | 8.09e-04 | 4 | 219 | 2 | PF00136 | |
| Domain | VINCULIN_1 | 8.09e-04 | 4 | 219 | 2 | PS00663 | |
| Domain | DNA-dir_DNA_pol_B | 8.09e-04 | 4 | 219 | 2 | IPR006172 | |
| Domain | DNA-dir_DNA_pol_B_exonuc | 8.09e-04 | 4 | 219 | 2 | IPR006133 | |
| Domain | DNA-dir_DNA_pol_B_multi_dom | 8.09e-04 | 4 | 219 | 2 | IPR006134 | |
| Domain | POLBc | 8.09e-04 | 4 | 219 | 2 | SM00486 | |
| Domain | VDCC_a2/dsu | 8.09e-04 | 4 | 219 | 2 | IPR013680 | |
| Domain | VGCC_alpha2 | 8.09e-04 | 4 | 219 | 2 | PF08473 | |
| Domain | Vinculin_CS | 8.09e-04 | 4 | 219 | 2 | IPR000633 | |
| Domain | DNA_pol_B_exo1 | 8.09e-04 | 4 | 219 | 2 | PF03104 | |
| Domain | - | 9.20e-04 | 64 | 219 | 5 | 3.40.50.1000 | |
| Domain | Ald_DH_CS_CYS | 9.58e-04 | 17 | 219 | 3 | IPR016160 | |
| Domain | Cation_ATPase_N | 1.14e-03 | 18 | 219 | 3 | PF00690 | |
| Domain | ALDEHYDE_DEHYDR_GLU | 1.14e-03 | 18 | 219 | 3 | PS00687 | |
| Domain | Cation_ATPase_N | 1.14e-03 | 18 | 219 | 3 | SM00831 | |
| Domain | ALDEHYDE_DEHYDR_CYS | 1.14e-03 | 18 | 219 | 3 | PS00070 | |
| Domain | PolyA | 1.34e-03 | 5 | 219 | 2 | SM00517 | |
| Domain | PABP | 1.34e-03 | 5 | 219 | 2 | PF00658 | |
| Domain | Vinculin | 1.34e-03 | 5 | 219 | 2 | PF01044 | |
| Domain | PABC | 1.34e-03 | 5 | 219 | 2 | PS51309 | |
| Domain | VWA_N | 1.34e-03 | 5 | 219 | 2 | IPR013608 | |
| Domain | VWA_N | 1.34e-03 | 5 | 219 | 2 | PF08399 | |
| Domain | - | 1.34e-03 | 5 | 219 | 2 | 1.10.1900.10 | |
| Domain | P-type_TPase_V | 1.34e-03 | 5 | 219 | 2 | IPR006544 | |
| Domain | PABP_1234 | 1.34e-03 | 5 | 219 | 2 | IPR006515 | |
| Domain | PABP_HYD | 1.34e-03 | 5 | 219 | 2 | IPR002004 | |
| Domain | Aldedh | 1.34e-03 | 19 | 219 | 3 | PF00171 | |
| Domain | ATPase_P-typ_cation-transptr_N | 1.34e-03 | 19 | 219 | 3 | IPR004014 | |
| Domain | Aldehyde_DH_dom | 1.34e-03 | 19 | 219 | 3 | IPR015590 | |
| Domain | - | 1.34e-03 | 19 | 219 | 3 | 3.40.309.10 | |
| Domain | - | 1.34e-03 | 19 | 219 | 3 | 3.40.605.10 | |
| Domain | Ald_DH_C | 1.34e-03 | 19 | 219 | 3 | IPR016163 | |
| Domain | Ald_DH_N | 1.34e-03 | 19 | 219 | 3 | IPR016162 | |
| Domain | Ald_DH/histidinol_DH | 1.34e-03 | 19 | 219 | 3 | IPR016161 | |
| Domain | - | 1.56e-03 | 20 | 219 | 3 | 3.40.50.1240 | |
| Domain | His_PPase_superfam | 1.56e-03 | 20 | 219 | 3 | IPR029033 | |
| Domain | Helicase_C | 1.64e-03 | 107 | 219 | 6 | PF00271 | |
| Domain | HELICc | 1.64e-03 | 107 | 219 | 6 | SM00490 | |
| Domain | Helicase_C | 1.72e-03 | 108 | 219 | 6 | IPR001650 | |
| Domain | - | 1.77e-03 | 74 | 219 | 5 | 3.40.50.410 | |
| Domain | DEXDc | 1.80e-03 | 109 | 219 | 6 | SM00487 | |
| Domain | HELICASE_CTER | 1.80e-03 | 109 | 219 | 6 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.80e-03 | 109 | 219 | 6 | PS51192 | |
| Domain | UDPGT | 1.81e-03 | 21 | 219 | 3 | PF00201 | |
| Domain | UDP_glucos_trans | 1.81e-03 | 21 | 219 | 3 | IPR002213 | |
| Domain | UDPGT | 1.81e-03 | 21 | 219 | 3 | PS00375 | |
| Domain | Helicase_ATP-bd | 1.89e-03 | 110 | 219 | 6 | IPR014001 | |
| Domain | Acid_Pase_AS | 1.99e-03 | 6 | 219 | 2 | IPR033379 | |
| Domain | Ryanodine_recept-rel | 1.99e-03 | 6 | 219 | 2 | IPR015925 | |
| Domain | - | 1.99e-03 | 6 | 219 | 2 | 1.25.10.30 | |
| Domain | RIH_assoc-dom | 1.99e-03 | 6 | 219 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 1.99e-03 | 6 | 219 | 2 | PF08709 | |
| Domain | RIH_assoc | 1.99e-03 | 6 | 219 | 2 | PF08454 | |
| Domain | RIH_dom | 1.99e-03 | 6 | 219 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.99e-03 | 6 | 219 | 2 | IPR014821 | |
| Domain | RYDR_ITPR | 1.99e-03 | 6 | 219 | 2 | PF01365 | |
| Domain | Ion_trans_dom | 2.26e-03 | 114 | 219 | 6 | IPR005821 | |
| Domain | Ion_trans | 2.26e-03 | 114 | 219 | 6 | PF00520 | |
| Domain | HIS_ACID_PHOSPHAT_2 | 2.76e-03 | 7 | 219 | 2 | PS00778 | |
| Domain | APC_su10/DOC_dom | 2.76e-03 | 7 | 219 | 2 | IPR004939 | |
| Domain | ANAPC10 | 2.76e-03 | 7 | 219 | 2 | PF03256 | |
| Domain | HIS_ACID_PHOSPHAT_1 | 2.76e-03 | 7 | 219 | 2 | PS00616 | |
| Domain | APC10 | 2.76e-03 | 7 | 219 | 2 | SM01337 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | EPRS1 RPL29 MYCBP2 RPS3 CFL1 ACO2 PARK7 ACTN1 RRM1 SUCLG2 BIRC6 HNRNPU NUP205 BLMH RECQL5 HERC2 VCL GNL3L AIMP2 NUP107 POLE CAPN2 BAZ1B ABCF2 CHD7 PABPC1 USP5 NOP58 SNW1 HLTF CCT6B ATIC SNRPA ALDH7A1 SON | 1.72e-12 | 1353 | 221 | 35 | 29467282 |
| Pubmed | EPRS1 RPL29 NCALD ACADS MYCBP2 ACO2 PARK7 SRPRA TSG101 BIRC6 HNRNPU STX5 RNF10 AK1 NOS1 HCN4 KALRN ATP13A1 HCN1 CAPN2 MYO18A ADGRL1 PPP6R1 IDH3G CDC42BPB ARFGAP2 ELFN1 CTNNA2 PEAK1 CTNND2 FLOT1 | 1.03e-11 | 1139 | 221 | 31 | 36417873 | |
| Pubmed | EPRS1 RPL29 ACADS RPS3 CFL1 ACO2 PARK7 PABPC4 SUCLG2 PGRMC1 HNRNPU RECQL5 PCBP4 TALDO1 VCL CAPS ABCF2 IDH3G PABPC1 RHOC NOP58 CCT6B ATIC FLOT1 ATP2A1 MAP3K2 | 1.31e-11 | 803 | 221 | 26 | 36517590 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | EPRS1 RPL29 MYCBP2 RPS3 ACO1 CFL1 ACO2 PARK7 ACTN1 ACE RYR1 HNRNPU TXNRD1 LPXN TALDO1 VCL AP1M2 DPP3 PABPC1 RHOC USP5 NOP58 NT5C2 ATIC PEAK1 ATP2A1 | 1.46e-11 | 807 | 221 | 26 | 30575818 |
| Pubmed | EPRS1 RPL29 ATP7B MYCBP2 ORC6 RPS3 CFL1 CC2D1A BIRC6 PGRMC1 HNRNPU NUP205 ITPR2 MGAT1 PIK3C3 LPXN HERC2 DPP4 GNL3L AIMP2 NUP107 ATP13A1 MYO18A ABCF2 DDX55 PABPC1 NOP58 HLTF ATIC FLOT1 DNAJC3 | 1.94e-11 | 1168 | 221 | 31 | 19946888 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | EPHX2 CDHR2 FAM209A ACO1 PARK7 CC2D1A TSG101 ACTN1 ACE ITIH4 RYR1 BLMH S100A4 BLVRB AK1 NID1 VCL DOP1B DPP4 COL6A3 KALRN CAPN2 SHMT1 CDC42BPB RHOC VPS13D ATIC FLOT1 | 8.52e-11 | 1016 | 221 | 28 | 19056867 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | EPRS1 RPL29 RPS3 CFL1 ACO2 PARK7 PABPC4 TSG101 PGRMC1 HNRNPU SPDL1 NUP205 BLMH TALDO1 VCL GNL3L NUP107 ATP13A1 POLE BAZ1B XIAP ABCF2 IDH3G DDX55 PABPC1 MRM3 NOP58 SNW1 ATIC ATM PEAK1 SNRPA FLOT1 | 1.43e-10 | 1425 | 221 | 33 | 30948266 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | EPRS1 RPL29 MYCBP2 RPS3 CFL1 PARK7 PABPC4 MCL1 SRPRA TSPYL1 RRM1 BIRC6 PGRMC1 HNRNPU NUP205 MAGED4 CLP1 GNL3L AIMP2 NUP107 POLE SHMT1 ABCF2 IDH3G PABPC1 NOP58 SNW1 HLTF CCT6B SNRPA | 5.33e-10 | 1257 | 221 | 30 | 37317656 |
| Pubmed | EPRS1 RPL29 RPS3 CFL1 ACO2 PARK7 PABPC4 TSG101 ACTN1 HNRNPU ITPR2 TTC7B SVIL DNAH6 NOS1 DAGLA VCL KALRN PPP1R9A MYO18A DPYSL4 ADGRL1 CDC42BPB PABPC1 USP5 AP3B2 CTNNA2 PEAK1 CTNND2 FLOT1 ALDH7A1 CACNA2D3 | 6.68e-10 | 1431 | 221 | 32 | 37142655 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EPRS1 RPL29 MYCBP2 RPS3 CFL1 RBM10 PABPC4 ACTN1 PGRMC1 HNRNPU NUP205 ITPR2 BLMH SVIL HERC2 NUP107 PPP1R9A BAZ1B ABCF2 PABPC1 NOP58 SNW1 ATIC SNRPA FLOT1 SON | 2.35e-09 | 1024 | 221 | 26 | 24711643 |
| Pubmed | MYCBP2 CFL1 PARK7 HCN2 ITIH4 HNRNPU SVIL KCNJ16 HERC2 NOS1 GOLGA1 HCN4 KALRN HCN1 PPP1R9A DPYSL4 CHD7 PPP6R1 CDC42BPB PABPC1 RHOC SNW1 NT5C2 CTNNA2 CTNND2 | 3.14e-09 | 963 | 221 | 25 | 28671696 | |
| Pubmed | EPRS1 RPS3 CFL1 RBM10 PARK7 PABPC4 MCL1 SRPRA TSPYL1 RRM1 HNRNPU TXNRD1 ALDH1L2 DAGLA AIMP2 BAZ1B ABCF2 TEC DDX55 PABPC1 ZCCHC3 RHOC NOP58 CTNNA2 SNRPA | 3.71e-09 | 971 | 221 | 25 | 33306668 | |
| Pubmed | EPRS1 CFL1 PABPC4 CC2D1A SRPRA SUCLG2 PGRMC1 NUP205 BLVRB PIN4 SVIL HERC2 RBM47 TALDO1 DPP4 GNL3L AIMP2 ATP13A1 CHD7 DDX55 CDC42BPB PABPC1 RHOC MRM3 NOP58 SNW1 GZF1 CTNNA2 FLOT1 SON | 3.98e-09 | 1371 | 221 | 30 | 36244648 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | EPRS1 RPL29 RPS3 ACO1 CFL1 PABPC4 ACTN1 RRM1 BIRC6 HNRNPU SPDL1 NUP205 TXNRD1 RPP25 BLMH S100A4 SNX6 TALDO1 VCL AIMP2 CAPN2 SHMT1 ABCF2 TUT1 DPP3 PABPC1 USP5 NT5C2 ATIC SNRPA ALDH7A1 | 3.98e-09 | 1455 | 221 | 31 | 22863883 |
| Pubmed | EPRS1 MYCBP2 ORC6 RBM10 NAB2 PABPC4 DACH1 CC2D1A ACTN1 RRM1 HNRNPU TXNRD1 BLMH GSE1 PIN4 TALDO1 AIMP2 CHD7 DPP3 DDX55 PABPC1 NOP58 SNW1 HLTF ATIC SNRPA | 1.07e-08 | 1103 | 221 | 26 | 34189442 | |
| Pubmed | MYCBP2 ACO1 SUCLG2 BIRC6 RYR1 GSE1 SNX6 RNF10 VCL COL6A3 AMPD1 KALRN ABCF2 CDC42BPB CIPC ATP2A1 SON | 2.43e-08 | 497 | 221 | 17 | 23414517 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | EPHX2 CDHR2 ACO1 CFL1 PARK7 MB GAS6 CC2D1A TSG101 ACTN1 ACE ITIH4 MGAT1 ALDH1L2 NID1 TALDO1 DOP1B DPP4 COL6A3 SHMT1 PABPC1 ATIC FLOT1 CDH15 ALDH7A1 | 2.50e-08 | 1070 | 221 | 25 | 23533145 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | EPRS1 RPL29 RPS3 CFL1 ACO2 PABPC4 SRPRA SUCLG2 ITIH4 PTGR3 HNRNPU NUP205 S100A4 BLVRB GSE1 PPIP5K2 TALDO1 AIMP2 BAZ1B ABCF2 CHD7 PABPC1 ZCCHC3 NOP58 SNW1 HLTF SNRPA SON | 2.58e-08 | 1318 | 221 | 28 | 30463901 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | EPRS1 RPL29 RPS3 CFL1 PABPC4 MCL1 ACTN1 RRM1 SUCLG2 HNRNPU SNX6 TALDO1 DNAH6 GNL3L AIMP2 ABCF2 IDH3G PABPC1 USP5 SEPHS2 AP3B2 FLOT1 | 2.91e-08 | 847 | 221 | 22 | 35235311 |
| Pubmed | RPS3 RBM10 PABPC4 HNRNPU DNAH6 COL6A3 MYO18A PABPC1 TENM3 CCT6B CTNNA2 | 3.63e-08 | 187 | 221 | 11 | 26460568 | |
| Pubmed | EPHX2 EPRS1 CFL1 RBM10 ACO2 PARK7 MCL1 ACTN1 MMP20 SUCLG2 PGRMC1 HNRNPU TXNRD1 RPP25 AK1 TIGAR IDH3G AP3B2 RAB11FIP5 ATIC ATP2A1 ALDH7A1 | 3.73e-08 | 859 | 221 | 22 | 31536960 | |
| Pubmed | MYCBP2 PABPC4 ACTN1 BIRC6 NUP205 HERC2 VCL NUP107 POLE BAZ1B CHD7 PABPC1 ZCCHC3 USP5 NOP58 SNW1 ATIC ATM SON | 4.66e-08 | 653 | 221 | 19 | 22586326 | |
| Pubmed | WBP2 EPRS1 RPL29 RPS3 CFL1 RBM10 PARK7 PABPC4 TSG101 HNRNPU RECQL5 TIGAR AIMP2 ABCF2 PABPC1 USP5 NOP58 CCT6B | 9.77e-08 | 615 | 221 | 18 | 31048545 | |
| Pubmed | EPRS1 ABCA4 RPS3 CFL1 ACO2 PARK7 HNRNPU AK1 ALDH3A1 TALDO1 MYO18A DPYSL4 IDH3G PABPC1 USP5 AP3B2 SNRPA | 1.10e-07 | 552 | 221 | 17 | 36293380 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | MYCBP2 RPS3 RBM10 ACO2 TSG101 PGRMC1 HNRNPU NUP205 PIN4 PPIP5K2 CLP1 DNMT3B KALRN MYO18A DPYSL4 CHD7 DDX55 INTS6 NOP58 SNW1 ATM SNRPA FLOT1 SON | 1.26e-07 | 1082 | 221 | 24 | 38697112 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | WBP2 RPL29 ACO1 CFL1 NAB2 ACTN1 RRM1 SUCLG2 HNRNPU NUP205 TXNRD1 BLMH BLVRB SNX6 TALDO1 VCL AMPD1 CAPN2 MYO18A DPYSL4 PABPC1 USP5 NOP58 SNW1 ATIC ALDH7A1 SON | 2.01e-07 | 1367 | 221 | 27 | 32687490 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | EPRS1 RPL29 RPS3 CFL1 ACO2 PABPC4 CD109 ACTN1 HNRNPU BLMH SVIL GNL3L PPP1R9A MYO18A ABCF2 DDX55 PABPC1 NOP58 RAB11FIP5 SNRPA FLOT1 SON | 2.07e-07 | 949 | 221 | 22 | 36574265 |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | EPRS1 RPL29 RPS3 CFL1 PABPC4 CD109 SRPRA ACTN1 HNRNPU S100A4 SVIL AIMP2 MYO18A CDC42BPB PABPC1 ATIC FLOT1 | 2.20e-07 | 580 | 221 | 17 | 35676659 |
| Pubmed | EPRS1 RPL29 RPS3 CFL1 RBM10 PABPC4 PGRMC1 HNRNPU ALDH1L2 AMPD1 AIMP2 POLE BIRC2 XIAP ABCF2 PABPC1 NOP58 SNRPA SON | 2.34e-07 | 725 | 221 | 19 | 27025967 | |
| Pubmed | 2.53e-07 | 3 | 221 | 3 | 21945247 | ||
| Pubmed | 2.53e-07 | 3 | 221 | 3 | 22006928 | ||
| Pubmed | 2.53e-07 | 3 | 221 | 3 | 26314849 | ||
| Pubmed | Ventricular HCN channels decrease the repolarization reserve in the hypertrophic heart. | 2.53e-07 | 3 | 221 | 3 | 22652004 | |
| Pubmed | 2.53e-07 | 3 | 221 | 3 | 21187420 | ||
| Pubmed | 2.53e-07 | 3 | 221 | 3 | 33181864 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | EPRS1 RPL29 MYCBP2 RPS3 CFL1 RBM10 PARK7 PABPC4 ACTN1 PGRMC1 HNRNPU BLMH SNX6 SVIL TALDO1 VCL AIMP2 MYO18A SHMT1 PABPC1 USP5 NOP58 ATIC ALDH7A1 | 3.74e-07 | 1149 | 221 | 24 | 35446349 |
| Pubmed | RIPOR2 RBM10 GSE1 SGSM2 ARHGEF9 DOP1B PPP1R9A ADGRL1 PPP6R1 ZHX2 TENM3 PPIP5K1 CIPC SON | 4.04e-07 | 407 | 221 | 14 | 12693553 | |
| Pubmed | EPRS1 CFL1 PARK7 PABPC4 HNRNPU TALDO1 PABPC1 SNW1 ATIC FLOT1 SON | 4.32e-07 | 239 | 221 | 11 | 26641092 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | MYCBP2 PABPC4 TSPYL1 BIRC6 HNRNPU NUP205 PIK3C3 HERC2 AIMP2 POLE MYO18A BAZ1B ABCF2 DDX55 ZCCHC3 MRM3 NOP58 SNW1 SON | 4.67e-07 | 759 | 221 | 19 | 35915203 |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | EPRS1 ACADS RPS3 ACTN1 NOS1 ATP13A1 HCN1 CAPN2 MYO18A IDH3G PABPC1 USP5 AP3B2 CCT6B RAB11FIP5 ATP12A SNRPA | 5.68e-07 | 621 | 221 | 17 | 22794259 |
| Pubmed | EPRS1 RPL29 RPS3 CFL1 RBM10 PABPC4 TSPYL1 HNRNPU GNL3L AIMP2 NUP107 BAZ1B ABCF2 DDX55 PABPC1 NOP58 SNW1 SEC61G FLOT1 SON | 5.73e-07 | 847 | 221 | 20 | 35850772 | |
| Pubmed | WBP2 EPRS1 PDE9A MYCBP2 ACO1 TSG101 ACTN1 TTC7B SNX6 SGSM2 RNF10 KCNN1 HERC2 DOP1B KALRN ATP13A1 HCN1 BIRC2 REV3L CDC42BPB CIPC ATIC ATM CTNND2 FLOT1 | 7.74e-07 | 1285 | 221 | 25 | 35914814 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | EPRS1 RPL29 RPS3 CFL1 RBM10 ACO2 PABPC4 ACTN1 HNRNPU TALDO1 SHMT1 XIAP PABPC1 ZCCHC3 NOP58 SNW1 SNRPA SON | 8.55e-07 | 714 | 221 | 18 | 28302793 |
| Pubmed | 1.01e-06 | 4 | 221 | 3 | 16043489 | ||
| Pubmed | 1.01e-06 | 4 | 221 | 3 | 20140458 | ||
| Pubmed | 1.01e-06 | 4 | 221 | 3 | 22748890 | ||
| Pubmed | Identification of a gene encoding a hyperpolarization-activated pacemaker channel of brain. | 1.01e-06 | 4 | 221 | 3 | 9630217 | |
| Pubmed | 1.01e-06 | 4 | 221 | 3 | 18414036 | ||
| Pubmed | 1.01e-06 | 4 | 221 | 3 | 9405696 | ||
| Pubmed | 1.01e-06 | 4 | 221 | 3 | 12928435 | ||
| Pubmed | 1.01e-06 | 4 | 221 | 3 | 21615589 | ||
| Pubmed | MYCBP2 PARK7 CC2D1A SRPRA RRM1 PGRMC1 ITPR2 STX5 SNX6 HERC2 VCL TIGAR NUP107 ATP13A1 POLE MYO18A SHMT1 BAZ1B PPP6R1 CDC42BPB NOP58 SNW1 RAB11FIP5 ATM PEAK1 FLOT1 DNAJC3 | 1.02e-06 | 1487 | 221 | 27 | 33957083 | |
| Pubmed | RPL29 RPS3 CFL1 HNRNPU NUP205 BLMH RECQL5 SVIL ALDH3A1 BAZ1B PABPC1 NOP58 SNW1 SNRPA FLOT1 SMC1B SON | 1.10e-06 | 652 | 221 | 17 | 31180492 | |
| Pubmed | RIPOR2 CFL1 ACTN1 PGRMC1 AK1 BAZ1B PPP6R1 USP5 TENM3 POLI ATIC PEAK1 | 1.21e-06 | 322 | 221 | 12 | 26514267 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | EPRS1 RPS3 CFL1 PARK7 PABPC4 CC2D1A SRPRA ACTN1 RRM1 BIRC6 HNRNPU TXNRD1 TIGAR AIMP2 CAPN2 ABCF2 PPP6R1 DDX55 PABPC1 MRM3 USP5 NOP58 SNW1 HLTF SNRPA SON | 1.32e-06 | 1415 | 221 | 26 | 28515276 |
| Pubmed | Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. | CFL1 PARK7 PABPC4 CC2D1A SRPRA HNRNPU TXNRD1 LPXN CDC42BPB PABPC1 ZCCHC3 PEAK1 | 1.42e-06 | 327 | 221 | 12 | 15592455 |
| Pubmed | Pacsin 2 is required for the maintenance of a normal cardiac function in the developing mouse heart. | 1.51e-06 | 14 | 221 | 4 | 29107716 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | EPRS1 RPL29 RPS3 CFL1 PABPC4 CD109 SRPRA ACTN1 HNRNPU NUP205 ITPR2 SVIL GNL3L AIMP2 MYO18A BAZ1B ABCF2 DDX55 PABPC1 ZCCHC3 NOP58 SNW1 SNRPA FLOT1 | 1.81e-06 | 1257 | 221 | 24 | 36526897 |
| Pubmed | EPRS1 NCALD CFL1 ACO2 MB PABPC4 ACTN1 HNRNPU NUP205 AK1 KDR PPIP5K2 DNAH6 DNMT3B PPP1R9A MYO18A ABCF2 DDX55 PABPC1 SEPHS2 MTTP ATM ATP12A ATP2A1 DNAJC3 CFAP46 | 1.87e-06 | 1442 | 221 | 26 | 35575683 | |
| Pubmed | 2.51e-06 | 5 | 221 | 3 | 20957035 | ||
| Pubmed | Regulation of HCN channel surface expression by a novel C-terminal protein-protein interaction. | 2.51e-06 | 5 | 221 | 3 | 15564593 | |
| Pubmed | 2.51e-06 | 5 | 221 | 3 | 34429357 | ||
| Pubmed | WBP2 EPRS1 MYCBP2 RPS3 CFL1 RBM10 DACH1 CC2D1A ACTN1 SPDL1 VCL BAZ1B NOP58 SNW1 PEAK1 | 2.74e-06 | 549 | 221 | 15 | 38280479 | |
| Pubmed | EPRS1 RPL29 RPS3 PABPC4 TSG101 ACTN1 HNRNPU NUP205 VCL NUP107 BAZ1B PABPC1 NOP58 FLOT1 | 3.09e-06 | 484 | 221 | 14 | 31995728 | |
| Pubmed | RPS3 CFL1 ACTN1 HNRNPU NUP205 DOCK5 NUP107 MYO18A ABCF2 PABPC1 SNW1 | 3.36e-06 | 295 | 221 | 11 | 26209609 | |
| Pubmed | EPRS1 RPS3 CFL1 ACO2 PABPC4 SRPRA PGRMC1 HNRNPU NUP205 STX5 PIN4 AIMP2 MYO18A PABPC1 ZCCHC3 NOP58 ALDH7A1 | 3.53e-06 | 711 | 221 | 17 | 33022573 | |
| Pubmed | PABPC4 SRPRA ACTN1 TSPYL1 BLVRB MGAT1 RECQL5 ARHGEF9 HERC2 CLP1 GNL3L ATP13A1 PPP1R9A BAZ1B ABCF2 CHD7 DDX55 ZHX2 CDC42BPB MRM3 INTS6 GZF1 HLTF CTNNA2 CTNND2 SON | 3.68e-06 | 1497 | 221 | 26 | 31527615 | |
| Pubmed | 3.79e-06 | 142 | 221 | 8 | 30809309 | ||
| Pubmed | EPRS1 CC2D1A HNRNPU BLVRB SVIL PPIP5K2 NUP107 PPP1R9A CDC42BPB USP5 ATIC MAP3K2 | 3.81e-06 | 360 | 221 | 12 | 33111431 | |
| Pubmed | RPL29 PABPC4 HNRNPU GNL3L ABCF2 DDX55 PABPC1 NOP58 SNW1 HLTF | 4.26e-06 | 245 | 221 | 10 | 35652658 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | RPS3 PARK7 SRPRA TSG101 HNRNPU SVIL AK1 PPIP5K2 NUP107 SHMT1 CDC42BPB SNW1 AP3B2 CTNNA2 | 4.28e-06 | 498 | 221 | 14 | 36634849 |
| Pubmed | ACTN1 HCN2 ITPR2 HERC2 DAGLA VCL MYO18A ADGRL1 CDC42BPB PABPC1 ELFN1 AP3B2 FLOT1 | 4.35e-06 | 430 | 221 | 13 | 32581705 | |
| Pubmed | 4.99e-06 | 6 | 221 | 3 | 25761792 | ||
| Pubmed | EPRS1 RPL29 RPS3 CFL1 PARK7 PABPC4 TSPYL1 HNRNPU GSE1 AIMP2 ABCF2 PABPC1 INTS6 GZF1 HLTF MAP3K2 | 5.26e-06 | 655 | 221 | 16 | 35819319 | |
| Pubmed | ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease. | 6.41e-06 | 202 | 221 | 9 | 33601422 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | EPRS1 RPS3 CFL1 ACO2 NAB2 CD109 MCL1 SRPRA PGRMC1 HNRNPU SPDL1 MGAT1 ALDH1L2 NID1 DNAH6 GOLGA1 ATP13A1 ABCF2 IDH3G PABPC1 RHOC MRM3 NT5C2 RAB11FIP5 DNAJC3 | 6.59e-06 | 1451 | 221 | 25 | 30550785 |
| Pubmed | RPL29 MYCBP2 RPS3 CFL1 ACTN1 HNRNPU BLMH ARHGEF9 ATP13A1 SHMT1 PABPC1 MAP3K2 | 6.95e-06 | 382 | 221 | 12 | 37249651 | |
| Pubmed | The inhibitors of apoptosis (IAPs) and their emerging role in cancer. | 8.69e-06 | 7 | 221 | 3 | 9916987 | |
| Pubmed | Transcription profiling of HCN-channel isotypes throughout mouse cardiac development. | 8.69e-06 | 7 | 221 | 3 | 19421833 | |
| Pubmed | 8.69e-06 | 7 | 221 | 3 | 9990849 | ||
| Pubmed | 8.69e-06 | 7 | 221 | 3 | 26074487 | ||
| Pubmed | 8.69e-06 | 7 | 221 | 3 | 27956497 | ||
| Pubmed | 8.80e-06 | 114 | 221 | 7 | 28245920 | ||
| Pubmed | EPRS1 RPL29 ACO2 PABPC4 ACTN1 HNRNPU BLMH VCL MYO18A ABCF2 PABPC1 | 8.91e-06 | 327 | 221 | 11 | 31409639 | |
| Pubmed | 9.06e-06 | 267 | 221 | 10 | 33417871 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EPRS1 RPL29 CFL1 RBM10 PARK7 CC2D1A HNRNPU GSE1 VCL GNL3L NUP107 BAZ1B DPYSL4 XIAP PPP6R1 PABPC1 SNW1 ATIC SON | 9.45e-06 | 934 | 221 | 19 | 33916271 |
| Pubmed | CDHR2 ACO1 PARK7 CD109 TSG101 RRM1 RYR1 SPDL1 ITPR2 MGAT1 HS6ST1 RECQL5 LPXN ARHGEF9 HRH1 KDR RBM47 DOP1B HCN4 REV3L NOP58 NT5C2 CCT6B | 9.50e-06 | 1293 | 221 | 23 | 15342556 | |
| Pubmed | Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation. | EPRS1 RPS3 RBM10 PABPC4 SRPRA HNRNPU NUP205 BLMH ALDH1L2 PABPC1 | 9.67e-06 | 269 | 221 | 10 | 30442662 |
| Pubmed | 1.02e-05 | 214 | 221 | 9 | 22199357 | ||
| Pubmed | EPRS1 RPS3 CFL1 ACTN1 RRM1 HNRNPU TALDO1 VCL CRABP1 RHOC ATIC SNRPA | 1.02e-05 | 397 | 221 | 12 | 21319273 | |
| Pubmed | EPRS1 RPS3 RBM10 PABPC4 ACTN1 HNRNPU SVIL PPP1R9A MYO18A PABPC1 | 1.13e-05 | 274 | 221 | 10 | 34244482 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | RPL29 RPS3 CFL1 PABPC4 ACTN1 HNRNPU ITPR2 S100A4 SVIL HERC2 MYO18A ABCF2 CHD7 PABPC1 NOP58 | 1.31e-05 | 626 | 221 | 15 | 33644029 |
| Pubmed | 1.38e-05 | 8 | 221 | 3 | 32093886 | ||
| Pubmed | 1.38e-05 | 8 | 221 | 3 | 10944468 | ||
| Pubmed | 1.38e-05 | 8 | 221 | 3 | 20886612 | ||
| Pubmed | Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33. | 1.38e-05 | 8 | 221 | 3 | 22451720 | |
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 1.38e-05 | 8 | 221 | 3 | 19033399 | |
| Pubmed | ABL2 MYCBP2 RPS3 HCN2 PGRMC1 HCN1 MYO18A ADGRL1 RAB11FIP5 CTNNA2 CTNND2 | 1.55e-05 | 347 | 221 | 11 | 17114649 | |
| Pubmed | RBM10 ACO2 PABPC4 DACH1 CC2D1A PGRMC1 NUP205 GSE1 RECQL5 SVIL HERC2 CLP1 VCL NUP107 MYO18A BAZ1B CHD7 PPP6R1 ZHX2 PABPC1 ZCCHC3 SNW1 NT5C2 FLOT1 | 1.55e-05 | 1429 | 221 | 24 | 35140242 | |
| Pubmed | Cellular substrates and pro-apoptotic function of the human HtrA4 protease. | 1.61e-05 | 173 | 221 | 8 | 31470122 | |
| Interaction | AGR2 interactions | EPRS1 RPL29 MYCBP2 RPS3 ACO1 CFL1 ACO2 PARK7 ACTN1 ACE RYR1 HNRNPU TXNRD1 BLVRB LPXN ALDH3A1 TALDO1 VCL AP1M2 DPP3 PABPC1 RHOC USP5 NOP58 NT5C2 ATIC PEAK1 ATP2A1 | 8.77e-07 | 934 | 216 | 28 | int:AGR2 |
| Interaction | KIF20A interactions | RPS3 NUP210L CFL1 PABPC4 CD109 ACTN1 TSPYL1 ITIH4 HNRNPU NUP205 ITPR2 DOCK5 SVIL HERC2 AIMP2 PPP1R9A MYO18A BAZ1B ADGRL1 CDC42BPB PABPC1 NOP58 ELFN1 HLTF PPIP5K1 RORA FLOT1 ATP2A1 SON | 2.93e-06 | 1052 | 216 | 29 | int:KIF20A |
| Interaction | EED interactions | EPRS1 RPL29 MYCBP2 RPS3 CFL1 ACTN1 RRM1 BIRC6 HNRNPU NUP205 SNX6 NRK SVIL RNF10 NID1 HERC2 DNMT3B NUP107 CAPN2 MYO18A BAZ1B ABCF2 CHD7 CDC42BPB PABPC1 RHOC ARFGAP2 USP5 NOP58 MTTP ATIC SNRPA FLOT1 SON | 1.20e-05 | 1445 | 216 | 34 | int:EED |
| Interaction | KCTD13 interactions | EPRS1 RPL29 RPS3 CFL1 ACO2 PARK7 PABPC4 TSG101 ACTN1 HNRNPU ITPR2 TTC7B SVIL DNAH6 NOS1 DAGLA VCL KALRN PPP1R9A CAPN2 MYO18A DPYSL4 ADGRL1 CDC42BPB PABPC1 USP5 AP3B2 CTNNA2 PEAK1 CTNND2 FLOT1 ALDH7A1 CACNA2D3 | 1.45e-05 | 1394 | 216 | 33 | int:KCTD13 |
| Interaction | GAN interactions | RPS3 RBM10 PABPC4 HNRNPU S100A4 DNAH6 COL6A3 MYO18A PABPC1 TENM3 CCT6B CTNNA2 | 1.94e-05 | 253 | 216 | 12 | int:GAN |
| Interaction | UGT2B28 interactions | 2.37e-05 | 6 | 216 | 3 | int:UGT2B28 | |
| Interaction | ECT2 interactions | EPRS1 RPL29 MYCBP2 RPS3 CFL1 PARK7 PABPC4 CD109 ACTN1 SUCLG2 HNRNPU ITPR2 SVIL RBM47 DOP1B PPP1R9A CAPN2 MYO18A PABPC1 RHOC NOP58 FLOT1 ATP2A1 SON | 3.04e-05 | 887 | 216 | 24 | int:ECT2 |
| Interaction | C9orf72 interactions | EPRS1 RPL29 MYCBP2 RPS3 CFL1 PARK7 PABPC4 MCL1 SRPRA TSPYL1 RRM1 BIRC6 PGRMC1 HNRNPU NUP205 MAGED4 CLP1 VCL GNL3L AIMP2 NUP107 POLE SHMT1 ABCF2 IDH3G PABPC1 NOP58 SNW1 HLTF CCT6B SNRPA | 3.12e-05 | 1319 | 216 | 31 | int:C9orf72 |
| Interaction | EMC2 interactions | EPRS1 RBM10 CD109 RRM1 PGRMC1 ATP13A1 RHOC RHOH NOP58 P2RY6 HLTF ATIC ATP2A1 DNAJC3 ALDH7A1 | 3.97e-05 | 411 | 216 | 15 | int:EMC2 |
| GeneFamily | Ring finger proteins|Baculoviral IAP repeat containing|Caspase recruitment domain containing | 3.23e-05 | 8 | 153 | 3 | 419 | |
| GeneFamily | Cyclic nucleotide gated channels | 6.83e-05 | 10 | 153 | 3 | 250 | |
| GeneFamily | Aldehyde dehydrogenases | 5.21e-04 | 19 | 153 | 3 | 398 | |
| GeneFamily | Parkinson disease associated genes|ATPase orphan transporters | 7.00e-04 | 5 | 153 | 2 | 1213 | |
| GeneFamily | DNA polymerases | 9.29e-04 | 23 | 153 | 3 | 535 | |
| GeneFamily | RNA binding motif containing | 2.27e-03 | 213 | 153 | 7 | 725 | |
| GeneFamily | UDP glucuronosyltransferases | 2.46e-03 | 32 | 153 | 3 | 363 | |
| Coexpression | GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_DN | ACO2 SUCLG2 ZRANB3 NUP205 HRH1 CLP1 NUP107 SHMT1 PABPC1 RHOH NOP58 | 1.10e-06 | 200 | 220 | 11 | M4885 |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_UP | EPRS1 ACADS MYCBP2 BIRC6 BLMH RBM47 ATP13A1 BIRC2 CALHM2 SNW1 FHDC1 | 1.10e-06 | 200 | 220 | 11 | M4021 |
| Coexpression | GSE24972_WT_VS_IRF8_KO_MARGINAL_ZONE_SPLEEN_BCELL_UP | 7.94e-06 | 200 | 220 | 10 | M8097 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP | 7.94e-06 | 200 | 220 | 10 | M3446 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDC_UP | 7.94e-06 | 200 | 220 | 10 | M3901 | |
| Coexpression | GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_DN | 7.94e-06 | 200 | 220 | 10 | M6636 | |
| Coexpression | GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_UP | MYCBP2 TSG101 ACTN1 PGRMC1 TXNRD1 TALDO1 VCL CAPN2 CHD7 IDH3G | 7.94e-06 | 200 | 220 | 10 | M9083 |
| Coexpression | GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_UP | 4.08e-05 | 194 | 220 | 9 | M5136 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | EPRS1 MYCBP2 SPDL1 ITPR2 NID1 PPIP5K2 DPP4 BAZ1B BIRC2 REV3L HLTF RORA ATM CTNND2 DNAJC3 MAP3K2 SON | 4.31e-05 | 656 | 220 | 17 | M18979 |
| Coexpression | GSE3720_UNSTIM_VS_LPS_STIM_VD2_GAMMADELTA_TCELL_DN | 4.73e-05 | 153 | 220 | 8 | M6338 | |
| Coexpression | WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP | 4.85e-05 | 113 | 220 | 7 | M1260 | |
| Coexpression | PEDRIOLI_MIR31_TARGETS_DN | ABCA4 MYCBP2 FEM1C ACE TXNRD1 SVIL NID1 PPP1R9A ODAD2 SLIT3 UHMK1 HLTF FLOT1 | 5.11e-05 | 413 | 220 | 13 | M2494 |
| Coexpression | GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_DN | 5.17e-05 | 200 | 220 | 9 | M4583 | |
| Coexpression | GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_UP | 5.17e-05 | 200 | 220 | 9 | M8550 | |
| Coexpression | GSE5142_CTRL_VS_HTERT_TRANSDUCED_CD8_TCELL_EARLY_PASSAGE_CLONE_UP | 5.17e-05 | 200 | 220 | 9 | M6549 | |
| Coexpression | GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_DN | 5.17e-05 | 200 | 220 | 9 | M9081 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | RIPOR2 ATP7B ACO1 ACO2 TSG101 PGRMC1 ITPR2 TXNRD1 BLMH BLVRB PIK3C3 VCL DNMT3B AIMP2 NUP107 SHMT1 BIRC2 ABCF2 DPP3 ARFGAP2 RHOH INTS6 SEPHS2 SNW1 HLTF ATIC | 1.27e-04 | 1399 | 220 | 26 | M535 |
| Coexpression | HEVNER_CORTEX_CAUDAL_CORTICAL_PLATE | 1.27e-04 | 31 | 220 | 4 | MM439 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | NOX5 SFI1 ITPR2 PIK3C3 PIN4 KDR NIPA2 HERC2 PPIP5K2 CAPN2 MYO18A BAZ1B ADGRL1 CHD7 REV3L CDC42BPB SNW1 ATM | 1.32e-04 | 790 | 220 | 18 | M12490 |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | EPRS1 ACO1 SRPRA NUP205 NRK PCBP4 VCL BAZ1B XIAP ABCF2 PPP6R1 SNW1 ATIC SON | 1.36e-04 | 519 | 220 | 14 | M3395 |
| Coexpression | ZHENG_CORD_BLOOD_C1_PUTATIVE_MEGAKARYOCYTE_PROGENITOR | 1.81e-04 | 98 | 220 | 6 | M39210 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | EPRS1 ACO1 SRPRA NUP205 NRK PCBP4 VCL BAZ1B XIAP ABCF2 PPP6R1 SNW1 ATIC SON | 2.17e-04 | 543 | 220 | 14 | MM997 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | ORC6 RRM1 ZRANB3 SPDL1 NUP205 ALDH1L2 PPIP5K2 PCBP4 POLE CHD7 REV3L NOP58 AP3B2 NT5C2 CTNND2 CACNA2D3 | 2.19e-04 | 680 | 220 | 16 | MM456 |
| Coexpression | BROWNE_HCMV_INFECTION_24HR_DN | 2.31e-04 | 145 | 220 | 7 | M14098 | |
| Coexpression | BLUM_RESPONSE_TO_SALIRASIB_UP | 2.40e-04 | 245 | 220 | 9 | M7300 | |
| Coexpression | GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_UP | 2.63e-04 | 196 | 220 | 8 | M3351 | |
| Coexpression | GSE14000_4H_VS_16H_LPS_DC_UP | 2.72e-04 | 197 | 220 | 8 | M3354 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_BCELL_DN | 2.82e-04 | 198 | 220 | 8 | M5411 | |
| Coexpression | GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_UP | 2.91e-04 | 199 | 220 | 8 | M8035 | |
| Coexpression | GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_DN | 2.91e-04 | 199 | 220 | 8 | M316 | |
| Coexpression | GSE43955_10H_VS_30H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN | 2.91e-04 | 199 | 220 | 8 | M9697 | |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDC_DN | 2.91e-04 | 199 | 220 | 8 | M3795 | |
| Coexpression | GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_DN | 2.91e-04 | 199 | 220 | 8 | M4964 | |
| Coexpression | GSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_UP | 2.91e-04 | 199 | 220 | 8 | M7710 | |
| Coexpression | GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_DN | 2.91e-04 | 199 | 220 | 8 | M6964 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_UP | 3.01e-04 | 200 | 220 | 8 | M4528 | |
| Coexpression | GSE2826_WT_VS_BTK_KO_BCELL_UP | 3.01e-04 | 200 | 220 | 8 | M4898 | |
| Coexpression | GSE27786_LSK_VS_BCELL_UP | 3.01e-04 | 200 | 220 | 8 | M4743 | |
| Coexpression | GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP | 3.01e-04 | 200 | 220 | 8 | M3459 | |
| Coexpression | GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_DN | 3.01e-04 | 200 | 220 | 8 | M8545 | |
| Coexpression | GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_DN | 3.01e-04 | 200 | 220 | 8 | M4962 | |
| Coexpression | GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_UP | 3.01e-04 | 200 | 220 | 8 | M8517 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_PRO_BCELL_UP | 3.01e-04 | 200 | 220 | 8 | M8843 | |
| Coexpression | GSE2585_AIRE_KO_VS_WT_CD80_HIGH_MTEC_UP | 3.01e-04 | 200 | 220 | 8 | M6266 | |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP | 3.01e-04 | 200 | 220 | 8 | M7978 | |
| Coexpression | GSE4748_CTRL_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN | 3.01e-04 | 200 | 220 | 8 | M6485 | |
| Coexpression | HALLMARK_MYC_TARGETS_V1 | 3.01e-04 | 200 | 220 | 8 | M5926 | |
| Coexpression | HALLMARK_MYOGENESIS | 3.01e-04 | 200 | 220 | 8 | M5909 | |
| Coexpression | GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_UP | 3.01e-04 | 200 | 220 | 8 | M5261 | |
| Coexpression | GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_DN | 3.01e-04 | 200 | 220 | 8 | M9272 | |
| Coexpression | KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_DN | 3.01e-04 | 200 | 220 | 8 | M3017 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-08 | 182 | 221 | 10 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-08 | 182 | 221 | 10 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.24e-08 | 195 | 221 | 10 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.24e-08 | 195 | 221 | 10 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.50e-08 | 196 | 221 | 10 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.46e-07 | 165 | 221 | 9 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.46e-07 | 165 | 221 | 9 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.91e-07 | 179 | 221 | 9 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.21e-07 | 187 | 221 | 9 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.25e-07 | 192 | 221 | 9 | 9a2560921b8c0997e1788053004f099439e8f071 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.51e-07 | 197 | 221 | 9 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Neuron|3m / Sample Type, Dataset, Time_group, and Cell type. | 7.39e-07 | 200 | 221 | 9 | 3d134ae3c48ff4d1849db4fbe44ff73fb6c8c779 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Neuron|2m / Sample Type, Dataset, Time_group, and Cell type. | 7.39e-07 | 200 | 221 | 9 | a581f1704a87b0390e1e2ff85053367d85247755 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-06 | 173 | 221 | 8 | c63a615998d13b1725b5767f4ad2ec7e2b61db68 | |
| ToppCell | Ciliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.98e-06 | 177 | 221 | 8 | c38138fb5ad9766c2d240811210c854338cd612e | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.98e-06 | 184 | 221 | 8 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|Epithelial_cells / Location, Cell class and cell subclass | 4.48e-06 | 187 | 221 | 8 | 3cea677279e71fdb9879530dea10a5e6393beacd | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-06 | 187 | 221 | 8 | 3548a9914c2b2f5d805798ce22ab26eab6d03897 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.48e-06 | 187 | 221 | 8 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-06 | 187 | 221 | 8 | f4de4b7af1fdfbd628b1f509c060c1079d2e5437 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-06 | 187 | 221 | 8 | 81754e965848b718be20ee97ce072ce426938a69 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 4.66e-06 | 188 | 221 | 8 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like|lymph-node_spleen / Manually curated celltypes from each tissue | 5.04e-06 | 190 | 221 | 8 | 0c7eb8f4f2926af01bf44d5c9f239be7b81c67fe | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.23e-06 | 191 | 221 | 8 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.23e-06 | 191 | 221 | 8 | 053b3664f509baa107feaf90730f80ebf9ac8f14 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.23e-06 | 191 | 221 | 8 | 89d03c4133dda852a3713c0902a7d67941cf5b21 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.23e-06 | 191 | 221 | 8 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.44e-06 | 192 | 221 | 8 | b18ae7337eaad1315a5b0ee81c75f7606bd3c7fe | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.65e-06 | 193 | 221 | 8 | 7cd9671e0ac64f7f3607f564485c63abbb7e7a63 | |
| ToppCell | 10x5'-blood|World / Manually curated celltypes from each tissue | 5.65e-06 | 193 | 221 | 8 | 359d4242a7e5e51a3eaf6fe51bc1c653a402b054 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-Tnaive/CM_CD4|GI_small-bowel / Manually curated celltypes from each tissue | 5.65e-06 | 193 | 221 | 8 | 772e0370bda4bffed7798b8714e32c9e2a1d9b67 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.87e-06 | 194 | 221 | 8 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.87e-06 | 194 | 221 | 8 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.09e-06 | 195 | 221 | 8 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.09e-06 | 195 | 221 | 8 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | Control-Lymphoid-CD4_T_cells|Lymphoid / Condition, Lineage and Cell class | 6.09e-06 | 195 | 221 | 8 | 8679a122fe796b1eddef82460e985b3fd3b3a2a5 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Naive_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.09e-06 | 195 | 221 | 8 | c82d312ddc3231b0f3c58b2fb74af5dad24948e4 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 6.33e-06 | 196 | 221 | 8 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Naive_CD4+_T|T/NK_cells / Location, Cell class and cell subclass | 6.33e-06 | 196 | 221 | 8 | 9cc517373ce4374140ab153edc87ec5517ee1f63 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 6.33e-06 | 196 | 221 | 8 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | mLN-(2)_B_cell-(20)_B_cell_IgA_Plasma|mLN / shred on region, Cell_type, and subtype | 6.57e-06 | 197 | 221 | 8 | a39b384ee9824a08c3b544a9c3c7f0f95f08d6a7 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.57e-06 | 197 | 221 | 8 | 888f3b14133e078570ce4ad73d9a9ee3137f9cac | |
| ToppCell | mLN-B_cell-B_cell_IgA_Plasma|mLN / Region, Cell class and subclass | 6.57e-06 | 197 | 221 | 8 | 20822fce311326765b71337ce501ba44ea14f58f | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.82e-06 | 198 | 221 | 8 | 88bb764b21ca50e56f6c536a2d61d35afd8c3f36 | |
| ToppCell | Transverse-T_cell-Th17|T_cell / Region, Cell class and subclass | 6.82e-06 | 198 | 221 | 8 | 918068ffd682c896c11d576072bde270630539d9 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T8_naive-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.07e-06 | 199 | 221 | 8 | 67b9ff07de5be0895612c201cb21e66a3f88669a | |
| ToppCell | wk_15-18-Hematologic-Myeloid-SPP1+_Mac|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.07e-06 | 199 | 221 | 8 | c7fc2ac1601346aac71e7620a8a440fde8d92dbd | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 7.07e-06 | 199 | 221 | 8 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | wk_20-22-Hematologic-Myeloid-SPP1+_Mac|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.07e-06 | 199 | 221 | 8 | 7c19f1b1f4369edd035ca9cdcf4e653771fc4648 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.07e-06 | 199 | 221 | 8 | 56046a9f156d575c8810b7951043af471fb4c2ab | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T8_naive|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.07e-06 | 199 | 221 | 8 | e47f8314a4822bf00d0999316457f95c338585e1 | |
| ToppCell | Bac-SEP|World / Disease, Lineage and Cell Type | 7.33e-06 | 200 | 221 | 8 | fa4e027b304c3460489992b84ad81d355a5b55ea | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Neuron|6m / Sample Type, Dataset, Time_group, and Cell type. | 7.33e-06 | 200 | 221 | 8 | b5019b9d48f32cffd4645a5c0f3e0ac504ea8019 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.33e-06 | 200 | 221 | 8 | 88d713dfc792e7609bf7ecfb28f87cb748088570 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.33e-06 | 148 | 221 | 7 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.33e-06 | 148 | 221 | 7 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 1.06e-05 | 151 | 221 | 7 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | Enthrocyte|World / shred on cell class and cell subclass (v4) | 1.16e-05 | 153 | 221 | 7 | 654265f3c14344071b2af7ca05cbdbb17ce2c5d3 | |
| ToppCell | Enthrocyte|World / shred on cell class and cell subclass (v4) | 1.16e-05 | 153 | 221 | 7 | 105b91f5277d145f7717307d7eb9b7d8e8e23576 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 154 | 221 | 7 | 5ed64bbf603290e6dc34f81d145982690b89dd0d | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.26e-05 | 155 | 221 | 7 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.26e-05 | 155 | 221 | 7 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | severe_COVID-19-cDC|World / disease group, cell group and cell class (v2) | 1.31e-05 | 156 | 221 | 7 | 0a7e18ed8e13261c405eb6b9a183e99d8e1aac37 | |
| ToppCell | severe_COVID-19-cDC|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.37e-05 | 157 | 221 | 7 | ec1978e07e2214048d015d8bb793c1d9991f6e37 | |
| ToppCell | Healthy/Control-CD8+_T_naive|World / Disease group and Cell class | 1.43e-05 | 158 | 221 | 7 | 70680b29428b6bf882b1fae36f924b775961176b | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 160 | 221 | 7 | 822adcf5f9208f305cafffd8ed97f3a061e82b03 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-05 | 162 | 221 | 7 | 08ee7ae56e4927874515c47adc86dd845bf29a26 | |
| ToppCell | Endothelial-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.96e-05 | 166 | 221 | 7 | c286987ea4e511195607c87ec4529c2c2ed2122e | |
| ToppCell | COPD-Lymphoid-ILC_B|Lymphoid / Disease state, Lineage and Cell class | 1.96e-05 | 166 | 221 | 7 | e2cad1db536d5ad5a34c337c19b5e7d1a2851552 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-05 | 168 | 221 | 7 | d19a115365c5415e51c039718d7669de788fcf33 | |
| ToppCell | Control-Hematopoietic_Meg-Ery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.20e-05 | 169 | 221 | 7 | c2e2a7b89fe4a64d79efafdec037c4104f433061 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.20e-05 | 169 | 221 | 7 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.20e-05 | 169 | 221 | 7 | c6e5b179461996ced6c7621dc01cec00d401f4e8 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.20e-05 | 169 | 221 | 7 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.20e-05 | 169 | 221 | 7 | ea600c63cf9572bc4b3cad6392f67bd0d92c7fc9 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.38e-05 | 171 | 221 | 7 | bf475a69db04d4a886e442704955c6a96ff0de46 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD8-Tnaive/CM_CD8|blood / Manually curated celltypes from each tissue | 2.66e-05 | 174 | 221 | 7 | 8273de40552d1cca1a8fe3647fd5e4cb4bb70f99 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_DC-DC-DC2|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.66e-05 | 174 | 221 | 7 | 60ee7c6f1b6972e6647a16848087cc60e0060bbe | |
| ToppCell | (2)_NK/T-(23)_CD4+_T_cell-(232)_CD4+/CD45RA+_Naive_T_cell|(23)_CD4+_T_cell / immune cells in Peripheral Blood (logTPM normalization) | 2.76e-05 | 175 | 221 | 7 | fc40fda0fb9954cb0970c6ac71f6d6df7d27dc5c | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC-DC-tDC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.86e-05 | 176 | 221 | 7 | fb07a047a3a7a8d03bfcc28eea3da2eaa0f6b733 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Papillary_Renal_Cell_Carcinoma-8|TCGA-Kidney / Sample_Type by Project: Shred V9 | 3.18e-05 | 179 | 221 | 7 | 8c6a84602b079bd357c66244371eb23dd9384918 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.42e-05 | 181 | 221 | 7 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Hematologic-erythrocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-05 | 123 | 221 | 6 | 89415e47db7352ba385895e2127e683db131dc03 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-05 | 182 | 221 | 7 | cfba75c1ffc39ac76db9e8e27394731942882b30 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 3.54e-05 | 182 | 221 | 7 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | droplet-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-05 | 182 | 221 | 7 | d836bfdc298ecd3558a973e393a329eb8bd59d79 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-05 | 182 | 221 | 7 | 7e7c7a26460d3003cdf0c0ffb96208a566aa09a7 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-05 | 183 | 221 | 7 | 5cfcd589a480e67654d3d94e71916f122150db10 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-05 | 183 | 221 | 7 | c3ea8d3b916ffcaca3156e0d77a952724554c4ab | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_DC-DC-DC3|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.67e-05 | 183 | 221 | 7 | c6cac433ea7a3d60728efdc7051e09e01bb3ade5 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.67e-05 | 183 | 221 | 7 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-05 | 183 | 221 | 7 | 81003ddc24164959dd41bb12fcac72638789b8f2 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.80e-05 | 184 | 221 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.80e-05 | 184 | 221 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.80e-05 | 184 | 221 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | COVID-19_Convalescent-CD8+_T_naive|COVID-19_Convalescent / Disease condition and Cell class | 3.93e-05 | 185 | 221 | 7 | 2f8277a0b58fb0c49fa76ff6dfa6da961da1f9f5 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 3.93e-05 | 185 | 221 | 7 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.93e-05 | 185 | 221 | 7 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.93e-05 | 185 | 221 | 7 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.07e-05 | 186 | 221 | 7 | db4d9ac89cc1e55062ba888b3410b773340595dd | |
| Drug | Benperidol [2062-84-2]; Down 200; 10.4uM; HL60; HT_HG-U133A | NCALD GAS6 SFI1 ITPR2 TRANK1 SVIL PCBP4 DNMT3B CAPN2 IDH3G USP5 P2RY6 | 4.22e-07 | 195 | 218 | 12 | 2475_DN |
| Drug | AC1LA4KK | 4.33e-07 | 17 | 218 | 5 | CID000481402 | |
| Drug | AC1O7EMV | 5.95e-07 | 18 | 218 | 5 | CID005460650 | |
| Drug | ethanol | NOX5 MB TSG101 ACE BIRC6 ITIH4 PTGR3 S100A4 DOCK5 BLVRB PIK3C3 SCN3A KDR XYLB ALDH3A1 TALDO1 NOS1 POLE XDH REV3L CACNA2D4 POLI NT5C2 ALDH7A1 | 1.80e-06 | 837 | 218 | 24 | CID000000702 |
| Drug | D-ribofuranose | RRM1 RYR1 RPP25 AK1 XYLB PCBP4 TALDO1 TUT1 NOP58 P2RY6 ATIC SNRPA | 2.20e-06 | 228 | 218 | 12 | CID000000854 |
| Drug | adenine | NOX5 RRM1 RYR1 AK1 TALDO1 DNMT3B AMPD1 POLE SHMT1 XDH REV3L IDH3G PABPC1 P2RY6 UHMK1 POLI ATIC ALDH7A1 | 2.26e-06 | 510 | 218 | 18 | CID000000190 |
| Drug | Cisapride [81098-60-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A | CDHR2 CC2D1A S100A4 KCNN1 AK1 ADGRL1 ABCF2 CRABP1 CALHM2 TENM3 ATM | 3.01e-06 | 195 | 218 | 11 | 5305_UP |
| Drug | Methylprednisolone, 6-alpha [83-43-2]; Down 200; 10.6uM; HL60; HG-U133A | RBM10 SRPRA TSG101 RRM1 BLMH RECQL5 NOS1 ABCF2 RAB11FIP5 DNAJC3 SON | 3.17e-06 | 196 | 218 | 11 | 1567_DN |
| Drug | Delsoline [509-18-2]; Down 200; 8.6uM; HL60; HT_HG-U133A | ACADS CDHR2 GAS6 HNRNPU ITPR2 ARHGEF9 ADGRL1 ABCF2 IDH3G TEC CCT6B | 3.32e-06 | 197 | 218 | 11 | 2513_DN |
| Drug | Pyrimethamine [58-14-0]; Down 200; 16uM; PC3; HG-U133A | RBM10 ACO2 CC2D1A TSG101 GSE1 SGSM2 ABCF2 DPP3 IDH3G USP5 SON | 3.32e-06 | 197 | 218 | 11 | 1894_DN |
| Drug | NADP(H | NOX5 ACO1 ACO2 RRM1 BLVRB UGT2B10 XYLB UGT2B28 ALDH3A1 TALDO1 NOS1 SHMT1 XDH IDH3G UHMK1 RORA UGT2B11 ALDH7A1 | 3.57e-06 | 527 | 218 | 18 | CID000000930 |
| Drug | Esculin Hydrate [531-75-9]; Down 200; 11.8uM; HL60; HT_HG-U133A | NAB2 GAS6 HNRNPU ITPR2 RPP25 RECQL5 AK1 XYLB GOLGA1 IDH3G CCT6B | 3.85e-06 | 200 | 218 | 11 | 3052_DN |
| Drug | iron-nitrosyl | 4.29e-06 | 45 | 218 | 6 | CID000123668 | |
| Drug | hydroxyl radicals | EPHX2 ABCA4 ATP7B PDE9A ACADS MYCBP2 NOX5 ACO1 ACO2 MB GAS6 RRM1 ACE BLMH DOCK5 ALDH1L2 AK1 ALDH3A1 NOS1 COL6A3 AMPD1 SHMT1 XDH IDH3G USP5 POLI NT5C2 ATIC ATP12A ATP2A1 ALDH7A1 | 4.83e-06 | 1341 | 218 | 31 | CID000000961 |
| Drug | purine nucleoside | 4.94e-06 | 131 | 218 | 9 | CID000068368 | |
| Drug | Thapsigargin | EPRS1 NCALD ACO2 MCL1 SRPRA ACTN1 RRM1 PGRMC1 NUP205 S100A4 STX5 PIN4 MCEE VCL COL6A3 GNL3L NUP107 BAZ1B BIRC2 DPYSL4 XIAP ZHX2 CRABP1 RHOH INTS6 HLTF RAB11FIP5 ATP2A1 DNAJC3 CDH15 SON | 5.78e-06 | 1353 | 218 | 31 | ctd:D019284 |
| Drug | mono-(2-ethylhexyl)phthalate | EPHX2 ABCA4 ACADS CDHR2 NUP210L CD109 DACH1 RYR1 TXNRD1 RPP25 DOCK5 KCNJ16 VCL DNMT3B ATP13A4 KALRN DPYSL4 SLIT3 RORA ATP12A | 5.85e-06 | 658 | 218 | 20 | ctd:C016599 |
| Drug | fluoroacetaldehyde | 8.54e-06 | 5 | 218 | 3 | CID000073766 | |
| Drug | decanal | 1.07e-05 | 31 | 218 | 5 | CID000008175 | |
| Drug | dithionite | 1.48e-05 | 150 | 218 | 9 | CID000001086 | |
| Drug | AC1Q7BER | 1.70e-05 | 6 | 218 | 3 | CID000005702 | |
| Drug | 8-SPT | 1.74e-05 | 57 | 218 | 6 | CID000001908 | |
| Drug | zatebradine | 1.76e-05 | 17 | 218 | 4 | CID000065637 | |
| Drug | Acenocoumarol [152-72-7]; Down 200; 11.4uM; MCF7; HT_HG-U133A | HNRNPU RECQL5 SVIL GNL3L DPYSL4 ADGRL1 TUT1 RAB11FIP5 ATM SON | 1.79e-05 | 193 | 218 | 10 | 7232_DN |
| Drug | AC1L1CIR | 1.92e-05 | 58 | 218 | 6 | CID000001918 | |
| Drug | AC1L1KC5 | NOX5 RPS3 RRM1 RYR1 BLMH MYLK3 PIK3C3 NRK KCNN1 HRH1 XYLB NOS1 BIRC2 CACNA2D4 P2RY6 ATP2A1 CACNA2D3 | 1.97e-05 | 541 | 218 | 17 | CID000005428 |
| Drug | Colistin sulfate [1264-72-8]; Up 200; 3uM; MCF7; HT_HG-U133A | 2.05e-05 | 196 | 218 | 10 | 2851_UP | |
| Drug | Ketoconazole [65277-42-1]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 2.14e-05 | 197 | 218 | 10 | 5685_DN | |
| Drug | Enalapril maleate [76095-16-4]; Up 200; 8.2uM; PC3; HT_HG-U133A | MCL1 NID1 DAGLA GOLGA1 PPP1R9A BAZ1B ABCF2 TUT1 TENM3 ALDH7A1 | 2.14e-05 | 197 | 218 | 10 | 7265_UP |
| Drug | beta-NADP | ACADS NOX5 ACO1 ACO2 TSG101 RRM1 PTGR3 BLVRB ALDH3A1 TALDO1 NOS1 SHMT1 XDH IDH3G UHMK1 ALDH7A1 | 2.19e-05 | 490 | 218 | 16 | CID000000929 |
| Drug | Flavin-Adenine Dinucleotide | 2.25e-05 | 18 | 218 | 4 | DB03147 | |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Down 200; 14.2uM; MCF7; HT_HG-U133A | EPHX2 ACADS S100A4 AK1 GNL3L BAZ1B CCT6B RAB11FIP5 ATM ALDH7A1 | 2.33e-05 | 199 | 218 | 10 | 2270_DN |
| Drug | Tracazolate hydrochloride [41094-88-6]; Up 200; 11.8uM; HL60; HT_HG-U133A | 2.43e-05 | 200 | 218 | 10 | 2919_UP | |
| Drug | cobalt-60 | ATP7B ACO1 MB RYR1 PTGR3 RPP25 KDR MCEE XYLB TALDO1 DPP3 CACNA2D4 SNRPA CACNA2D3 | 2.59e-05 | 390 | 218 | 14 | CID000061492 |
| Drug | BAPTA-AM | NOX5 NAB2 RYR1 MYLK3 PIK3C3 KCNN1 HRH1 XYLB VCL CACNA2D4 P2RY6 ATP2A1 | 2.77e-05 | 293 | 218 | 12 | CID000002293 |
| Drug | reduced diphosphopyridine nucleotide | ACADS NOX5 ACO1 ACO2 BLVRB ALDH1L2 ALDH3A1 NOS1 SHMT1 XDH IDH3G ATIC ALDH7A1 | 2.80e-05 | 342 | 218 | 13 | CID000000928 |
| Drug | AC1NDTNH | RPL29 ABCA4 ATP7B SUCLG2 RYR1 MGAT1 STX5 PIK3C3 TALDO1 NUP107 POLE ADGRL1 ATIC | 2.88e-05 | 343 | 218 | 13 | CID004631409 |
| Drug | vitamin B | EPRS1 NOX5 HNRNPU S100A4 XYLB ALDH3A1 TALDO1 NOS1 MYO18A XDH IDH3G ALDH7A1 | 2.96e-05 | 295 | 218 | 12 | CID000000936 |
| Drug | cupric chloride | ATP7B MYCBP2 MB ITIH4 TXNRD1 BLMH BLVRB TALDO1 NOS1 DOP1B DPP4 NUP107 XDH XIAP ABCF2 IDH3G ATM FLOT1 | 3.39e-05 | 623 | 218 | 18 | ctd:C029892 |
| Drug | ivabradine | 3.39e-05 | 39 | 218 | 5 | CID000132999 | |
| Drug | 5-aminoimidazole-4-carboxamide | 3.71e-05 | 65 | 218 | 6 | CID000009679 | |
| Drug | nitrotyrosine | 3.88e-05 | 96 | 218 | 7 | CID000065124 | |
| Drug | malondialdehyde | 4.16e-05 | 213 | 218 | 10 | CID000010964 | |
| Drug | 2-deoxyadenosine | 4.37e-05 | 133 | 218 | 8 | CID000000636 | |
| Drug | C04226 | 4.68e-05 | 8 | 218 | 3 | CID000151255 | |
| Drug | citrazinic acid | 4.68e-05 | 8 | 218 | 3 | CID000007425 | |
| Drug | 3-methylitaconate | 4.68e-05 | 8 | 218 | 3 | CID006438940 | |
| Drug | arabinosyladenine | EPRS1 ATP7B PDE9A NOX5 RYR1 MYLK3 PIK3C3 AK1 DPP4 AMPD1 XDH IDH3G PABPC1 CACNA2D4 P2RY6 UHMK1 NT5C2 ATIC ATP2A1 ALDH7A1 | 4.77e-05 | 762 | 218 | 20 | CID000000191 |
| Drug | hypoxanthine | 5.46e-05 | 220 | 218 | 10 | CID000000790 | |
| Drug | AC1Q5V97 | 5.50e-05 | 43 | 218 | 5 | CID000000195 | |
| Drug | AC1L1ICD | 6.28e-05 | 23 | 218 | 4 | CID000004516 | |
| Drug | benzophenone-4-maleimide | 6.88e-05 | 45 | 218 | 5 | CID000146390 | |
| Drug | Superoxides | 6.89e-05 | 105 | 218 | 7 | ctd:D013481 | |
| Drug | acetate | NOX5 ACO1 ACO2 MB TSG101 MMP20 SUCLG2 ACE NRK XYLB ALDH3A1 TALDO1 XDH IDH3G INTS6 ATP2A1 ALDH7A1 | 7.01e-05 | 599 | 218 | 17 | CID000000175 |
| Drug | 2'-phosphoadenosine 5'-phosphate | 7.17e-05 | 73 | 218 | 6 | CID000002027 | |
| Drug | isoproterenol | PDE9A NOX5 SUCLG2 HCN2 ACE RYR1 PIN4 SCN3A HRH1 NOS1 DAGLA AMPD1 MYO18A CACNA2D4 P2RY6 ATP2A1 ALDH7A1 MYBPC3 | 8.44e-05 | 669 | 218 | 18 | CID000003779 |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; PC3; HT_HG-U133A | 8.69e-05 | 188 | 218 | 9 | 4545_DN | |
| Drug | iodonitrotetrazolium | 8.83e-05 | 25 | 218 | 4 | CID000064957 | |
| Drug | DETCA | 8.83e-05 | 25 | 218 | 4 | CID000151422 | |
| Drug | ATP,Gamma S | 9.05e-05 | 189 | 218 | 9 | CID000002028 | |
| Drug | cyclic d(ApAp | 9.13e-05 | 2 | 218 | 2 | CID000188955 | |
| Drug | oleandolide | 9.13e-05 | 2 | 218 | 2 | CID000443564 | |
| Drug | F-leu | 9.13e-05 | 2 | 218 | 2 | CID000071536 | |
| Drug | AC1L1XKM | 9.13e-05 | 2 | 218 | 2 | CID000011536 | |
| Drug | NF T | 9.43e-05 | 190 | 218 | 9 | CID006436102 | |
| Drug | arpromidine | 9.89e-05 | 10 | 218 | 3 | CID000065895 | |
| Drug | Aspirin | EPHX2 WBP2 GAS6 MCL1 ACE HNRNPU TXNRD1 BLMH S100A4 VCL AIMP2 CAPN2 BAZ1B XDH XIAP MTTP ATM ATP2A1 | 9.99e-05 | 678 | 218 | 18 | ctd:D001241 |
| Drug | oxygen | ACADS MYCBP2 NOX5 ACO1 ACO2 MB GAS6 RRM1 RYR1 BLMH BLVRB NOS1 SHMT1 XDH CDH15 | 1.00e-04 | 499 | 218 | 15 | CID000000977 |
| Drug | Tridihexethyl chloride; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.02e-04 | 192 | 218 | 9 | 3526_DN | |
| Drug | Ceforanide [60925-61-3]; Down 200; 7.6uM; PC3; HT_HG-U133A | 1.06e-04 | 193 | 218 | 9 | 6751_DN | |
| Drug | potassium | NOX5 SUCLG2 HCN2 ACE RYR1 PIK3C3 SCN3A KCNJ16 KCNN1 HRH1 TALDO1 NOS1 TIGAR HCN1 CACNA2D4 P2RY6 NT5C2 ATIC ATP12A SNRPA ATP2A1 ALDH7A1 CACNA2D3 | 1.08e-04 | 1008 | 218 | 23 | CID000000813 |
| Drug | H-89, Dihydrochloride; Up 200; 0.5uM; MCF7; HT_HG-U133A | 1.10e-04 | 194 | 218 | 9 | 6878_UP | |
| Drug | Albendazole [54965-21-8]; Down 200; 15uM; HL60; HG-U133A | 1.10e-04 | 194 | 218 | 9 | 1547_DN | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 1.12e-04 | 79 | 218 | 6 | CID005287890 | |
| Drug | Diethylcarbamazine citrate [1642-54-2]; Up 200; 10.2uM; HL60; HT_HG-U133A | 1.15e-04 | 195 | 218 | 9 | 2394_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HG-U133A | 1.19e-04 | 196 | 218 | 9 | 2035_UP | |
| Drug | Conessine [546-06-5]; Up 200; 11.2uM; PC3; HT_HG-U133A | 1.19e-04 | 196 | 218 | 9 | 4191_UP | |
| Drug | Isosorbide dinitrate [87-33-2]; Down 200; 17uM; HL60; HT_HG-U133A | 1.19e-04 | 196 | 218 | 9 | 2183_DN | |
| Drug | AC1L1B2Z | 1.21e-04 | 27 | 218 | 4 | CID000001261 | |
| Drug | brilliant blue | 1.21e-04 | 27 | 218 | 4 | CID000017559 | |
| Drug | Bi-E | 1.21e-04 | 27 | 218 | 4 | CID006914595 | |
| Drug | K-Cl | MB RYR1 BLMH PIN4 TALDO1 NOS1 AMPD1 POLE MYO18A REV3L CACNA2D4 P2RY6 POLI ATIC ATP2A1 ALDH7A1 | 1.22e-04 | 567 | 218 | 16 | CID000004873 |
| Drug | genistein; Down 200; 10uM; HL60; HT_HG-U133A | 1.24e-04 | 197 | 218 | 9 | 2695_DN | |
| Drug | Bepridil hydrochloride [74764-40-2]; Down 200; 10uM; PC3; HT_HG-U133A | 1.24e-04 | 197 | 218 | 9 | 4613_DN | |
| Drug | dinitrogen | 1.28e-04 | 81 | 218 | 6 | CID000000947 | |
| Drug | acridine | 1.28e-04 | 81 | 218 | 6 | CID000009215 | |
| Drug | Flufenamic acid [530-78-9]; Up 200; 14.2uM; HL60; HG-U133A | 1.29e-04 | 198 | 218 | 9 | 1420_UP | |
| Drug | Ramipril [87333-19-5]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.29e-04 | 198 | 218 | 9 | 7144_DN | |
| Drug | 0198306-0000 [212631-61-3]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.29e-04 | 198 | 218 | 9 | 7064_UP | |
| Drug | Imipenem [74431-23-5]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.29e-04 | 198 | 218 | 9 | 7294_UP | |
| Drug | Trimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; HL60; HT_HG-U133A | 1.29e-04 | 198 | 218 | 9 | 2146_DN | |
| Drug | Tolnaftate [2398-96-1]; Down 200; 13uM; MCF7; HT_HG-U133A | 1.29e-04 | 198 | 218 | 9 | 4805_DN | |
| Drug | Methocarbamol [532-03-6]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 1.29e-04 | 198 | 218 | 9 | 2274_DN | |
| Drug | Leucomisine [17946-87-1]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 1.34e-04 | 199 | 218 | 9 | 3546_UP | |
| Drug | Tyloxapol [25301-02-4]; Down 200; 4uM; HL60; HT_HG-U133A | 1.34e-04 | 199 | 218 | 9 | 3074_DN | |
| Drug | dichlorophenol | 1.39e-04 | 52 | 218 | 5 | CID000011334 | |
| Drug | Imipramine hydrochloride [113-52-0]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 1.39e-04 | 200 | 218 | 9 | 1685_UP | |
| Drug | Hesperidin [520-26-3]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 1.39e-04 | 200 | 218 | 9 | 2648_UP | |
| Drug | R)-PCV-TP | 1.40e-04 | 28 | 218 | 4 | CID000506602 | |
| Drug | Water Pollutants, Chemical | EPHX2 RIPOR2 ATP7B PABPC4 MCL1 SRPRA RRM1 TXNRD1 BLMH AK1 TALDO1 VCL DPP4 PPP1R9A PABPC1 RORA ATP2A1 | 1.41e-04 | 635 | 218 | 17 | ctd:D014874 |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 5.38e-05 | 2 | 217 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | meningitis (biomarker_via_orthology) | 5.38e-05 | 2 | 217 | 2 | DOID:9471 (biomarker_via_orthology) | |
| Disease | Colorectal Carcinoma | ABCA4 ATP7B RBM10 CD109 ZBTB8B TXNRD1 MYLK3 GSE1 HRH1 NID1 KDR WDR49 AMPD1 KALRN POLE CTNND2 | 7.01e-05 | 702 | 217 | 16 | C0009402 |
| Disease | Stomach Neoplasms | 7.61e-05 | 297 | 217 | 10 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 8.27e-05 | 300 | 217 | 10 | C0024623 | |
| Disease | sick sinus syndrome (implicated_via_orthology) | 1.61e-04 | 3 | 217 | 2 | DOID:13884 (implicated_via_orthology) | |
| Disease | lung cancer (is_implicated_in) | 2.19e-04 | 74 | 217 | 5 | DOID:1324 (is_implicated_in) | |
| Disease | phosphatidylcholine 36:4 measurement | 2.95e-04 | 18 | 217 | 3 | EFO_0010382 | |
| Disease | tyrosine-protein kinase TEC measurement | 3.20e-04 | 4 | 217 | 2 | EFO_0020830 | |
| Disease | Hereditary Diffuse Gastric Cancer | 3.42e-04 | 293 | 217 | 9 | C1708349 | |
| Disease | cystathionine measurement | 3.48e-04 | 19 | 217 | 3 | EFO_0010474 | |
| Disease | Malignant neoplasm of breast | ABCA4 ATP7B CFL1 ACO2 CD109 FEM1C GDF10 STX5 KDR HERC2 TREML1 DNMT3B KALRN SHMT1 BIRC2 XDH PABPC1 METTL6 ATM | 3.97e-04 | 1074 | 217 | 19 | C0006142 |
| Disease | Major Depressive Disorder | 4.62e-04 | 243 | 217 | 8 | C1269683 | |
| Disease | urinary metabolite measurement | 4.87e-04 | 245 | 217 | 8 | EFO_0005116 | |
| Disease | Insulinogenic index measurement | 5.31e-04 | 5 | 217 | 2 | EFO_0009961 | |
| Disease | focal segmental glomerulosclerosis 1 (implicated_via_orthology) | 5.31e-04 | 5 | 217 | 2 | DOID:0111128 (implicated_via_orthology) | |
| Disease | quality of life during menstruation measurement, Arthralgia | 5.31e-04 | 5 | 217 | 2 | EFO_0009366, HP_0002829 | |
| Disease | impotence (biomarker_via_orthology) | 5.45e-04 | 22 | 217 | 3 | DOID:1875 (biomarker_via_orthology) | |
| Disease | Immunologic Deficiency Syndromes | 6.23e-04 | 23 | 217 | 3 | C0021051 | |
| Disease | Breast Carcinoma | ATP7B CFL1 CD109 GDF10 KDR HERC2 DNMT3B SHMT1 BIRC2 PABPC1 METTL6 ATM | 6.85e-04 | 538 | 217 | 12 | C0678222 |
| Disease | Unipolar Depression | 7.01e-04 | 259 | 217 | 8 | C0041696 | |
| Disease | Adenocarcinoma of lung (disorder) | 8.66e-04 | 206 | 217 | 7 | C0152013 | |
| Disease | breast cancer (is_implicated_in) | 8.77e-04 | 150 | 217 | 6 | DOID:1612 (is_implicated_in) | |
| Disease | acute kidney failure (implicated_via_orthology) | 1.01e-03 | 27 | 217 | 3 | DOID:3021 (implicated_via_orthology) | |
| Disease | cerebral infarction (is_implicated_in) | 1.24e-03 | 29 | 217 | 3 | DOID:3526 (is_implicated_in) | |
| Disease | Congestive heart failure | 1.34e-03 | 110 | 217 | 5 | C0018802 | |
| Disease | Heart failure | 1.34e-03 | 110 | 217 | 5 | C0018801 | |
| Disease | Left-Sided Heart Failure | 1.34e-03 | 110 | 217 | 5 | C0023212 | |
| Disease | Heart Failure, Right-Sided | 1.34e-03 | 110 | 217 | 5 | C0235527 | |
| Disease | Heart Decompensation | 1.34e-03 | 110 | 217 | 5 | C1961112 | |
| Disease | Myocardial Failure | 1.34e-03 | 110 | 217 | 5 | C1959583 | |
| Disease | breast carcinoma (is_marker_for) | 1.44e-03 | 66 | 217 | 4 | DOID:3459 (is_marker_for) | |
| Disease | myocardial infarction (implicated_via_orthology) | 1.44e-03 | 66 | 217 | 4 | DOID:5844 (implicated_via_orthology) | |
| Disease | Large cell carcinoma of lung | 1.66e-03 | 32 | 217 | 3 | C0345958 | |
| Disease | Mammary Carcinoma, Human | ATP7B CFL1 CD109 GDF10 KDR DNMT3B SHMT1 BIRC2 PABPC1 METTL6 ATM | 1.86e-03 | 525 | 217 | 11 | C4704874 |
| Disease | Mammary Neoplasms, Human | ATP7B CFL1 CD109 GDF10 KDR DNMT3B SHMT1 BIRC2 PABPC1 METTL6 ATM | 1.86e-03 | 525 | 217 | 11 | C1257931 |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 1.87e-03 | 9 | 217 | 2 | EFO_0600040 | |
| Disease | immature platelet measurement | 1.90e-03 | 119 | 217 | 5 | EFO_0803541 | |
| Disease | Mammary Neoplasms | ATP7B CFL1 CD109 GDF10 KDR DNMT3B SHMT1 BIRC2 PABPC1 METTL6 ATM | 1.92e-03 | 527 | 217 | 11 | C1458155 |
| Disease | hypertension (is_implicated_in) | 2.05e-03 | 121 | 217 | 5 | DOID:10763 (is_implicated_in) | |
| Disease | colorectal cancer (is_implicated_in) | 2.05e-03 | 121 | 217 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | triacylglycerol 52:5 measurement | 2.16e-03 | 35 | 217 | 3 | EFO_0010417 | |
| Disease | Asthma, Occupational | 2.33e-03 | 10 | 217 | 2 | C0264423 | |
| Disease | familial hypercholesterolemia (is_implicated_in) | 2.33e-03 | 10 | 217 | 2 | DOID:13810 (is_implicated_in) | |
| Disease | non-alcoholic fatty liver disease (implicated_via_orthology) | 2.34e-03 | 36 | 217 | 3 | DOID:0080208 (implicated_via_orthology) | |
| Disease | metabolite measurement | EPHX2 ACADS ACE ZRANB3 ITPR2 UGT2B10 PCBP4 FOXO6 REV3L ATIC UGT2B11 | 3.06e-03 | 560 | 217 | 11 | EFO_0004725 |
| Disease | cannabis dependence | 3.29e-03 | 135 | 217 | 5 | EFO_0007191 | |
| Disease | neuroticism measurement, cognitive function measurement | NUP210L BIRC6 NOS1 DPP4 FOXO6 KALRN HCN1 TENM3 RAB11FIP5 RORA CTNND2 | 3.31e-03 | 566 | 217 | 11 | EFO_0007660, EFO_0008354 |
| Disease | retinopathy of prematurity (biomarker_via_orthology) | 3.38e-03 | 12 | 217 | 2 | DOID:13025 (biomarker_via_orthology) | |
| Disease | Nodular glomerulosclerosis | 3.40e-03 | 41 | 217 | 3 | C0017667 | |
| Disease | memory performance | 3.45e-03 | 409 | 217 | 9 | EFO_0004874 | |
| Disease | abdominal fat cell number | 3.56e-03 | 198 | 217 | 6 | EFO_0021534 | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 3.74e-03 | 200 | 217 | 6 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | serum iron measurement | 3.77e-03 | 86 | 217 | 4 | EFO_0006332 | |
| Disease | schizophrenia, type 2 diabetes mellitus | 3.90e-03 | 43 | 217 | 3 | MONDO_0005090, MONDO_0005148 | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 3.90e-03 | 43 | 217 | 3 | DOID:2476 (implicated_via_orthology) | |
| Disease | smoking behavior | 3.91e-03 | 341 | 217 | 8 | EFO_0004318 | |
| Disease | X-11444 measurement | 3.98e-03 | 13 | 217 | 2 | EFO_0021237 | |
| Disease | Diabetic Nephropathy | 4.16e-03 | 44 | 217 | 3 | C0011881 | |
| Disease | nevus count, cutaneous melanoma | 4.62e-03 | 91 | 217 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | triacylglycerol 52:1 measurement | 4.62e-03 | 14 | 217 | 2 | EFO_0010413 | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 5.31e-03 | 15 | 217 | 2 | EFO_0004599, EFO_0007892 | |
| Disease | glycerol-3-phosphate measurement | 5.31e-03 | 15 | 217 | 2 | EFO_0010488 | |
| Disease | Adenocarcinoma of large intestine | 5.58e-03 | 96 | 217 | 4 | C1319315 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 5.63e-03 | 49 | 217 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | birth weight, pelvic organ prolapse | 5.63e-03 | 49 | 217 | 3 | EFO_0004344, EFO_0004710 | |
| Disease | Schizophrenia | EPHX2 ACE PIK3C3 HRH1 KDR ALDH3A1 NOS1 DNMT3B SHMT1 SLIT3 UHMK1 ATM CTNNA2 CTNND2 | 6.01e-03 | 883 | 217 | 14 | C0036341 |
| Disease | triacylglycerol 50:5 measurement | 6.04e-03 | 16 | 217 | 2 | EFO_0010412 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 6.04e-03 | 16 | 217 | 2 | C0334634 | |
| Disease | Rolandic epilepsy | 6.04e-03 | 16 | 217 | 2 | Orphanet_1945 | |
| Disease | electrocardiography | 6.13e-03 | 530 | 217 | 10 | EFO_0004327 | |
| Disease | colorectal cancer (is_marker_for) | 6.21e-03 | 157 | 217 | 5 | DOID:9256 (is_marker_for) | |
| Disease | coronary artery disease (is_implicated_in) | 6.44e-03 | 100 | 217 | 4 | DOID:3393 (is_implicated_in) | |
| Disease | Benign neoplasm of stomach | 6.81e-03 | 17 | 217 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 6.81e-03 | 17 | 217 | 2 | C0496905 | |
| Disease | renal fibrosis (implicated_via_orthology) | 6.81e-03 | 17 | 217 | 2 | DOID:0050855 (implicated_via_orthology) | |
| Disease | protein C measurement | 6.81e-03 | 17 | 217 | 2 | EFO_0004633 | |
| Disease | Carcinoma in situ of stomach | 6.81e-03 | 17 | 217 | 2 | C0154060 | |
| Disease | glomerulonephritis (implicated_via_orthology) | 6.81e-03 | 17 | 217 | 2 | DOID:2921 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 7.25e-03 | 163 | 217 | 5 | DOID:1826 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VKLDTGKTFQAVMRF | 851 | P21399 | |
| EDMGRSAAVAKQALA | 391 | Q99798 | |
| FVSKVRNLKRAMATG | 126 | Q5JX71 | |
| EDFEMKKAAARAVTG | 61 | Q9UG63 | |
| NKSLKFKAAVMEIGR | 1391 | Q96N23 | |
| EEFMAAGHALRKKVQ | 791 | P0C7U0 | |
| AVSDGVIKVFNDMKV | 6 | P23528 | |
| ADQVMASFKILAGDK | 826 | P12814 | |
| FSHSRVEIMVKAKGQ | 286 | Q9Y6Q5 | |
| IVLSAGRKMAAAAAA | 21 | Q9NR09 | |
| MSQAREAVIAAAFAK | 176 | Q13938 | |
| FENVVAMKVGDKRDI | 696 | Q9UBC3 | |
| AKMANGTAGTKVALR | 1056 | P42684 | |
| MQRKLSVAIAFVGDA | 1066 | P78363 | |
| FIKEAAMAKLAASEA | 341 | P16219 | |
| FVNRSLAMEKIKCFG | 36 | P49902 | |
| LSRMKEVGKVFLATN | 236 | P49902 | |
| KEAGQRLATAMKLGF | 1161 | P12821 | |
| QAVSMFLGAVEEAKK | 376 | P49419 | |
| KEGRAALVTSFCMFK | 891 | Q4VNC1 | |
| VNDMGFEAAIKSKVA | 201 | P35670 | |
| GRNLADAAAFEKMII | 1271 | O94910 | |
| AFQEGIAKAKLVMRR | 886 | Q9UIG0 | |
| KALTVRNLQFEDGKM | 306 | Q3SY69 | |
| MSKISEAVKRARAAF | 1 | P30838 | |
| RAAEKKFGSNKAEMV | 216 | Q9HD20 | |
| AAAKAIGVLARNDMS | 301 | Q6PIY5 | |
| RAMKQKALSAAVADS | 891 | Q14687 | |
| GVRKDFMAHKAVLAA | 41 | Q9H116 | |
| ARNIVAAMKAHGVDK | 91 | P30043 | |
| DLVMKNALQRVKSGF | 321 | Q9BZ19 | |
| NALQRVKSGFRSEKM | 326 | Q9BZ19 | |
| VQAAEKSRKFMRPNA | 801 | Q8IYW2 | |
| ARQKFAGAKAISSDM | 421 | Q8N6H7 | |
| AMRNFAEKVFASEVK | 16 | P23109 | |
| AAATNAAIAEAMKVK | 331 | Q9UI36 | |
| AKAIAAEQRGTDMLA | 1826 | Q9P2D1 | |
| RRATVFLAMGKSKAA | 76 | Q13217 | |
| ITKNMENAKALRDAG | 971 | Q9UQB3 | |
| LAKAFQMVKSARPVA | 126 | Q4G0W2 | |
| AKSSRAAVGNKMFVK | 501 | O14983 | |
| TMANRELAFKAGDVI | 21 | O43307 | |
| IVAMIARGKNASDLF | 61 | Q13367 | |
| FKGSEMVVAGKLQDR | 486 | Q14624 | |
| TINVEFAKGSKRDMA | 376 | P98175 | |
| VIVYASAADKMKNRG | 181 | A0AV96 | |
| KALGVNAMLRKVAVA | 21 | P29762 | |
| NAMLRKVAVAAASKP | 26 | P29762 | |
| KINVAAKRGMKFVGF | 146 | Q52LD8 | |
| AGQMVDTKRLKDSAV | 576 | Q9BXF6 | |
| DTAKGAVETFMKLRA | 26 | Q9UL03 | |
| AEALKQGNAIMRKFL | 686 | P57740 | |
| AAQAETMFAGRKEKN | 1031 | Q14571 | |
| KMAFLTRVAKIQQGA | 1556 | Q92621 | |
| FLEKAIGLAVSRMAA | 431 | Q96PH1 | |
| ERALDTMNFDVIKGK | 66 | P11940 | |
| MLLNDRKVFVGRFKS | 161 | P11940 | |
| MDLKTAVFNAARDGK | 1 | Q96JP0 | |
| DAKRSMNIGIFLKQF | 171 | Q9C0D6 | |
| ALAAFTALMEGKINK | 56 | Q9Y2X3 | |
| ERALDTMNFDVIKGK | 66 | Q13310 | |
| MLLNDRKVFVGRFKS | 161 | Q13310 | |
| MAAANGSKKAERQKF | 386 | P57723 | |
| VVAAAAAKAKMATSI | 306 | Q96JG8 | |
| ETFQANRAKMAEGLA | 111 | Q92805 | |
| MARVLKAAAANAVGL | 1 | Q96PE7 | |
| RDSFKAFAKALGVMD | 391 | P26572 | |
| NKKLARSVGHIFEMD | 271 | Q15742 | |
| VLMDASAKFKELGIQ | 1746 | O95714 | |
| LRDAMVAKVNTSKGF | 76 | P00568 | |
| NKRDAKAAVVTGMEL | 671 | P54707 | |
| KAMLLKRQAFAVFSG | 2026 | Q9Y3R5 | |
| GALNKITFNTRFVMK | 261 | Q92952 | |
| ALADRAVFEKGMKAF | 411 | Q8NHQ9 | |
| EEAKLKKVARMGFNA | 11 | Q3SXM0 | |
| RKKGQEVFMAASQVL | 341 | P55107 | |
| FKSKDVMIFNGLVAL | 16 | Q9HA72 | |
| ARAEAEQMAKKAEAF | 331 | O75955 | |
| EKLKSGMRFNEVAAQ | 56 | Q9Y237 | |
| RLMSGKQAAAIIKAV | 266 | P55157 | |
| MASKRALVILAKGAE | 1 | Q99497 | |
| EFTCAAAVKARKAME | 1696 | Q92614 | |
| TFQKSKVADFLMQGR | 131 | Q32MK0 | |
| MAINGKVFDVTKGRK | 91 | O00264 | |
| KARTDQAAVMEKGRA | 1006 | Q9H792 | |
| FMDRDKVTKATAQIG | 501 | O76083 | |
| GNTMRKTEAKAFLHV | 961 | P14543 | |
| AVFSDVQRKALEKMF | 186 | A6NMT0 | |
| RKMCLFAGFQRKAVV | 591 | Q00839 | |
| RAVSMDNGAKFLRIK | 181 | A8MYZ6 | |
| EQKAKALRGRMFVLN | 1921 | O60229 | |
| EDLRSKAKIAFGQSM | 66 | Q9Y2U5 | |
| VSFRKDEKAMNGNLS | 311 | Q8N8Q9 | |
| FVAVVNKAMSAKFER | 331 | Q9NY33 | |
| NKAMSAKFERLVASA | 336 | Q9NY33 | |
| TEMQAKVAVRADAGK | 101 | O60711 | |
| RQFSKMGFVDNKRIA | 611 | P27487 | |
| LTAGEKAIAAERAMK | 496 | Q96PP9 | |
| TAKRLAEFLGDQMVK | 1056 | Q07864 | |
| AFGEVAVVKMKNTER | 86 | Q9Y5S2 | |
| AKKNLRGMAFFGLTE | 281 | O60243 | |
| VNKFSLRMFGSQKAV | 226 | Q9Y3Q4 | |
| AMLRFKASSKLGENF | 196 | Q8TCB7 | |
| GQAMAKRVKATILYA | 751 | P29475 | |
| AILKMQSAEGRRKVF | 236 | Q8NG75 | |
| MSKGAADAIAQAKRR | 256 | O14531 | |
| NGKMKAFLSLARFSD | 2381 | Q13315 | |
| TDNLKEKALSFMRQG | 946 | Q6YHK3 | |
| QAMKAAKEARKTAAG | 1186 | Q9BYE9 | |
| NAKAAKLSRFMFEGR | 1546 | Q9C0G6 | |
| VNKFSLRMFGSQKAV | 106 | O60741 | |
| MALKVATVAGSAAKA | 1 | P51553 | |
| LQAALMLRKKGFTTA | 106 | P34913 | |
| DKSERAFGVAFVKLM | 541 | Q9H7D0 | |
| VINAAKKIAEAGSRM | 741 | P26232 | |
| AAVGIQMKLEFFQRK | 816 | Q8IZS8 | |
| AAGVQMKLEFLQRKF | 851 | Q7Z3S7 | |
| NRDAVMKIAVAGDLF | 396 | Q14393 | |
| ELKRSSIMAFAIGNK | 571 | P12111 | |
| CKRSMDILKQAFVRG | 616 | Q6P1N0 | |
| GVSLKNMNKAERLTF | 351 | Q13867 | |
| KKLEQEMVLSQAFGR | 441 | Q9Y4D2 | |
| AKVRIFGNREMKAKA | 91 | Q86TM3 | |
| FGNREMKAKAKAAIE | 96 | Q86TM3 | |
| FVFTRLDGSMAQKKR | 876 | Q14527 | |
| RKAAKQLGFIMAAFI | 411 | P35367 | |
| LKFQAERDATQAGKM | 91 | Q8NDH6 | |
| MAGIAAKLAKDREAA | 1 | P17655 | |
| RGVLSFFSKKQMQDI | 566 | Q9UNA4 | |
| VIEEQGKRNFSKAMS | 3941 | P21817 | |
| TGKVFLNAMLDREKT | 101 | P55291 | |
| NKFSLRMFGSQKAVE | 176 | Q9UL51 | |
| KIFRQMDTNRDGKLS | 151 | P61601 | |
| TAFQGMLRKLDIKNE | 226 | Q07820 | |
| KAARMAVVVAAAFAI | 236 | Q15077 | |
| SEAVVVRAMKDKLGA | 1781 | Q5VU65 | |
| FEMATRAGLQVRKNK | 171 | P08134 | |
| NSMIRKIKELQAFFG | 66 | O60882 | |
| KEGSKIRNLMAFATA | 41 | Q9BUL9 | |
| GVAVALKQAMTLEFK | 311 | P34896 | |
| KTGAFTAVKVMNARK | 46 | Q7Z2Y5 | |
| NAKAMSARAEAIKAL | 61 | P47914 | |
| MARVDEAKKTFQAST | 696 | A8K8P3 | |
| DRKAAKTLGIVMGVF | 251 | Q9P1P4 | |
| VNFKGKLIMRFDDTN | 226 | P07814 | |
| MAAIKAVNSKAEVAR | 1 | Q92526 | |
| EGKALSELRAMAKAA | 96 | Q9NQ88 | |
| QAVTRKTFMQGEFLK | 641 | P0C7P3 | |
| FGLAVKKQSRSEAML | 266 | Q9BYT3 | |
| QFTVAGRMVKKGLAS | 1211 | O95425 | |
| AQYKVAIKAIREGAM | 391 | P42680 | |
| SAMAASILLFEGKRQ | 391 | Q9HC36 | |
| ILKMSSAQGRFKAFS | 276 | Q8NGC0 | |
| IKNAKDAGEMVRSFV | 866 | Q5T2S8 | |
| VNAMEGKKLAQDVRA | 131 | Q15669 | |
| KSKACFGAENLMRVL | 226 | Q9NVN8 | |
| RGFSVFFQMLVKAQK | 236 | Q8NA58 | |
| MRRFSQALLKGDKSV | 521 | Q8NEB9 | |
| GFLRSDKMAALFTKV | 61 | O43147 | |
| KGELSIQRMKALFES | 386 | Q96EA4 | |
| LGKRTDEAAFQKLMS | 46 | P26447 | |
| MAVQISKKRKFVADG | 1 | P23396 | |
| AGREFALMKTANGKI | 536 | O75592 | |
| MVATSGVKKAIFDRL | 161 | Q9Y5N6 | |
| AMARGSFLNAKRNKT | 121 | A3QJZ7 | |
| IVMNKGKAIFRFSAT | 91 | Q9NY46 | |
| FVRKVAGMDKQAKLS | 91 | Q9BXI2 | |
| ALLQTFRVKDGVKNM | 1096 | Q7RTU9 | |
| RLQDGASKMKQAFAT | 151 | Q9Y4F9 | |
| MAKSAEVKLAIFGRA | 1 | Q96A58 | |
| LMAKRIGKDLSNTFA | 96 | Q13190 | |
| VKSALEMGFNRDLVK | 396 | Q13490 | |
| EKAAVFRSMNSALGK | 251 | Q13155 | |
| KVARQLGMAAAESDK | 26 | Q9C0C6 | |
| MAEIFGTELTRNKKF | 41 | Q92989 | |
| FQLRALMQKARKTAG | 371 | Q99816 | |
| RGNKASDKATIMAFD | 386 | O94762 | |
| NNITRITKMDFAGLK | 71 | O75094 | |
| AAAKEAAQYGKKVMV | 176 | Q16881 | |
| KKLMSDNGVRVQRFF | 46 | Q96I99 | |
| IIAKMAAVSKASGRF | 346 | Q99611 | |
| VQEAIRMGFSFKDIK | 376 | P98170 | |
| GRRKKAEAAAAAMAT | 121 | Q9NUD5 | |
| GMNLINLAAVKFRKA | 171 | O60673 | |
| VLKMAAERGAFIDQS | 691 | P23921 | |
| KEFQKIAMATAIGFA | 31 | P60059 | |
| QKCLAVGMSRDAVKF | 131 | P35398 | |
| SFVMGEKIANLRVKN | 46 | Q8NDV3 | |
| ASVVMAADRSLKKGV | 111 | Q9H0U9 | |
| KALAEAADVGAQMIK | 151 | Q9H6E5 | |
| SFAQMLRVGKAKADV | 711 | Q8N5U6 | |
| TEGKNAVMRLCFLKA | 366 | Q8IV35 | |
| GAALAKMATARKRAQ | 166 | Q9NPI9 | |
| FKNGSLMREKIRNES | 336 | O75191 | |
| SSKGNDIIAAAKRMA | 981 | P18206 | |
| DKRKSVFSLAELGQM | 421 | Q9BY07 | |
| KDAAGIAMEAIAFAR | 496 | P08240 | |
| QVARQAKAFLSLGKM | 2456 | Q9P273 | |
| AKAFLSLGKMAEVQV | 2461 | Q9P273 | |
| MTADKLVFFVNGRKV | 1 | P47989 | |
| SQKVAAAMPVRAADK | 156 | Q13573 | |
| MKFKTGVKRAEISNA | 476 | P31939 | |
| DNIAHMKAKGAAVRL | 401 | O75310 | |
| DFFKNMVKSADGVIV | 186 | Q9UNH7 | |
| ADAQGAMNKALELFR | 126 | P02144 | |
| ASFFSKVMGILINRK | 121 | Q9UPN7 | |
| AMFDLAVDALATKGR | 251 | Q8N4Q0 | |
| VEEARKKMFNGTIQS | 326 | Q9Y6X8 | |
| SLMAAGKSARAVKVL | 406 | Q86TV6 | |
| NIAHMKAKGAAVRVD | 401 | P36537 | |
| KAKGAAVRVDFNTMS | 406 | P36537 | |
| ALLQTFRVKDGVKNM | 1096 | A6NGW2 | |
| DQMAVEKLSDGIRKF | 301 | P37837 | |
| QVAKGMEFLASRKCI | 1011 | P35968 | |
| QMTAAAFAKGLLALE | 571 | O43314 | |
| DNIAHMKAKGAAVRL | 401 | Q9BY64 | |
| SIQLFEAKLDKGARM | 841 | O15050 | |
| AAVVLFAVMAKRKQG | 176 | Q86YW5 | |
| DSKAAQKLLTGRMFD | 381 | Q8TAS1 | |
| SRSLKMRGQAFVIFK | 46 | P09012 | |
| ERAQKRSGNFSAAMK | 2351 | P18583 | |
| IVSMGFSRDQALKAL | 731 | P45974 | |
| RVQMTAAAFAKGLLA | 581 | Q6PFW1 | |
| ITRMFKQTAIAKAGA | 311 | Q5FWF4 | |
| EENFRGMLKSAATKV | 1311 | Q5THJ4 | |
| RVIFLSKGKDAMQSF | 56 | Q969T9 | |
| RKMEKEAAVAAAVAA | 126 | Q8NAP8 | |
| IADLMVGAKDQAVFK | 551 | Q14896 | |
| KLKALGMTASQDRAV | 1026 | Q9ULJ8 |